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ABSTRACT 
The accuracy of activity monitors are critical to the proper functioning of artificial 
pancreas (AP) systems. The objective of this thesis was to assess the accuracy of 
activity monitors at measuring energy expenditure (EE) during physical activity. In two 
separate studies, the Fitbit Charge 2 (FC2), Garmin vívosmart HR+ (GVHR+), Fitbit 
Ionic (FI), and Garmin vívosmart 3 (GV3) were assessed during 4-5 types of physical 
activity in 15-20 adults. In Study A, the GVHR+ displayed significantly less negative bias 
in EE than the FC2 (FC2: -19.3 ± 28.9%, GVHR+: -1.6 ± 30.6%, P<0.001). In Study B, 
the GV3 displayed less positive bias in EE than the FI (FI: 15.7 ± 36.0%, GV3: 7.0 ± 
36.3%). The GV3 significantly overestimated EE in T1D subjects compared to healthy 
controls. None of the activity monitors tested are ready to be incorporated into an AP 
system, but the GV3 is approaching the accuracy required. 
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1. INTRODUCTION 
1.1. TYPE 1 DIABETES 
Type 1 diabetes (T1D) is an autoimmune disease characterized by the 
destruction of insulin-producing -cells in the pancreas, resulting in total insulin 
deficiency and hyperglycemia in the body (1). Consequently, individuals with T1D are 
required to administer insulin exogenously to manage blood glucose (BG) to try and 
maintain it within euglycemic range (3.9-10.0 mmol/L) (1–3). Over time, T1D can lead to 
long-term complications, such as cardiovascular disease (CVD), retinopathy, 
nephropathy, and neuropathy (4). 
The exact number of individuals with T1D around the world is unknown, but in 
the United States, it is estimated that up to 3 million individuals live with T1D (1). 
Approximately 64 000 new cases of T1D develop annually in the United States in 
individuals between 0 to 64 years of age (5). Although no formal assessment has been 
conducted in Canada, it is estimated that more than 300 000 Canadians are living with 
T1D (6). 
Individuals with T1D are prescribed to either multiple daily insulin injections (MDI) 
or continuous subcutaneous insulin infusion (CSII) to help manage glycemic control (7). 
With MDI, individuals administer a long-acting insulin with a syringe as a basal insulin 
and administer a rapid-acting insulin with a syringe prior to meals. The amount of rapid-
acting insulin administered is based on the grams of carbohydrates consumed (4). CSII 
involves the use of a small, portable device (i.e. an insulin pump) that infuses rapid-
acting insulin at a slow basal rate for 24 hours a day through a cannula inserted into 
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subcutaneous tissue. Individuals administer larger doses (i.e. boluses) of insulin at 
mealtime using the insulin pump based on the grams of carbohydrates consumed (8). 
Individuals with T1D use self-monitoring of blood glucose (SMBG) with a hand-
held glucose meter, or continuous glucose monitoring (CGM) with an implanted glucose 
sensor, to monitor their glucose control (7). SMBG typically involves piercing a finger 
with a lancet device to acquire a small drop of blood. The drop of blood is applied to a 
reagent strip that is inserted into a hand-held glucose meter (i.e. glucometer), which will 
measure glucose from the strip and display it on a screen (9). Most individuals using 
SMBG may test up to 6 to 10 times a day, but this can vary based on individual needs 
and motivations (7). CGM reduces the frequency of SMBG by providing measurements 
approximately every 5 minutes from a sensor inserted into subcutaneous tissue that 
measures the amount of glucose in interstitial fluid. The values are transmitted from the 
sensor to a data storage device or a sensor-associated app on the user’s smartphone 
via Bluetooth (10). SMBG and CGM allow individuals to monitor their BG and make 
necessary adjustments to insulin, food intake, or exercise to maintain glycemic control 
(7). 
Although SMBG and CGM can be effective tools for daily self-management of 
T1D, Diabetes Canada and the American Diabetes Association (ADA) recommend that 
overall glycemic management be assessed using glycated hemoglobin (HbA1c). HbA1c 
reflects an individual’s average glycemia over ~3 months. Diabetes Canada and the 
ADA recommend that adults with T1D maintain a HbA1c of 7% to reduce the risk of 
microvascular and macrovascular complications (11,12). In a longitudinal study of 1441 
people with T1D, participants on intensive insulin therapy (3 daily insulin injections with 
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MDI or CSII) with a mean HbA1c of 7.2% had a 63% (P0.002), 39-54% (39%: P0.002; 
54%: P<0.04), and 60% (P0.002) decrease in the risk of development and progression 
of retinopathy, nephropathy, and neuropathy, respectively, compared to participants on 
conventional therapy (1-2 daily insulin injections) with a mean HbA1c of 9.1% (13). At a 
30-year follow-up, the individuals on intensive insulin therapy (3 daily insulin injections 
with MDI or CSII) had a mean HbA1c of 7.8% and displayed a decrease in the risk of 
CVD by 30% (P=0.016) and the incidence of major cardiovascular events (nonfatal 
myocardial infarction, stroke, or cardiovascular death) by 32% (P=0.07) compared to the 
conventional therapy group (1-2 daily insulin injections), who had a mean HbA1c of 
8.2%. The lower HbA1c levels in the intensive insulin therapy group were determined to 
statistically account for all of the observed treatment effects on CVD risk in this group 
(14). 
Diabetes Canada and the ADA also recommend that adults with diabetes (type 1 
and type 2) engage in ≥150 minutes of moderate- (64-76% of a person’s maximum 
heart rate (HR)) to vigorous-intensity (>76% of a person’s maximum HR) aerobic 
exercise over at least 3 non-consecutive days of the week. Adults who are willing and 
able to can also perform interval training. Interval training consists of alternating 
between short periods (30 seconds to 3 minutes) of higher- and lower-intensity 
exercise. In addition to aerobic exercise, adults with diabetes should perform resistance 
exercise on ≥2 non-consecutive days of the week (15,16). However, most adults living 
with T1D do not meet these guidelines (17). Performing regular exercise training at 50-
90% of peak oxygen consumption (VO2 peak) at least twice a week for a minimum of 8 
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weeks has been demonstrated to decrease HbA1c by 0.78% (P<0.0001) and increase 
maximal oxygen consumption by 3.45 mL/kg/min (P=0.02) in individuals with T1D (18). 
 
1.2. ACTIVITY MONITORS 
Physical activity monitors have become increasingly popular in recent years, with 
423 new devices released from 2011 to 2017 (19). Activity monitors are small devices 
that are commonly worn on the wrist. They provide the user with real-time feedback on 
different physiological measurements and daily activities, such as HR, energy 
expenditure (EE), step count, and sleep duration (20). Through synchronization with a 
computer- or mobile-based app, users are able to receive more detailed feedback, such 
as summary data and progress towards personalized goals, as well as the ability to 
connect to social media and other health and fitness apps (20,21). Activity monitors can 
be effective tools for increasing physical activity (22). 
These devices can use one or more different types of sensors, including 
pedometers, accelerometers, gyroscopes, magnetometers, barometers, altimeters, 
global positioning systems (GPS), and photoplethysmography (PPG), to measure 
different metrics (19). Activity-specific algorithms incorporated into the device software 
analyze the pattern of signals from sensors to calculate EE and other physiological and 
activity outputs (23). Although the physical sensors in most devices are similar, the 
algorithms being used are unique to the manufacturer and are often proprietary (19). 
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1.3. ARTIFICIAL PANCREAS 
Artificial pancreas (AP) systems are being developed and tested to help 
individuals with T1D maintain euglycemia by automatically adjusting to variations 
caused by daily activities and disturbances. The four major sources of variations in BG 
concentrations are food, exercise, sleep, and stress (24). 
All AP systems consist of three basic components: a glucose sensor (e.g. CGM), 
insulin infusion mechanisms (e.g. insulin pumps), and decision-making algorithms that 
are used to calculate insulin infusion needs. Some researchers have proposed that 
physical activity monitors may help to better inform decision-making algorithms, since 
physical activity changes minute-by-minute insulin needs (25). To date, only one AP 
model (Medtronic MiniMed 670G Hybrid Closed-Loop System) has been approved for 
clinical use, but several others are in development. In models under development, 
glucose and physiological data gathered by sensors are inputted into a feedback control 
algorithm, which makes the necessary adjustments to an insulin pump to maintain 
euglycemia (24). In one study conducted by Turksoy et al. (26), the use of an AP 
system in individuals with T1D on a physically active day (20 minutes of treadmill 
running at 70-97% of their age-predicted maximum HR) resulted in a significant 
decrease in mild hypoglycemia (3.0-3.9 mmol/L) compared to individuals without an AP 
system (P<0.01). Zero percent (0/9) of participants using the AP system experienced 
severe hypoglycemia (<3.0 mmol/L) compared to 82% (9/11) of participants who were 
not using the AP system (P<0.01). In addition, there was a significant difference in the 
time spent in euglycemic range between the AP group and the group without AP (AP: 
58%; No AP: 54%; P<0.01). 
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For any medical device, including AP systems, the accuracy of the sensors (i.e. 
CGM, activity monitors, etc.) being used are critical to the proper functioning of the 
system, since they affect the decisions being made by the medical device and patient 
outcome. Therefore, it is important that the accuracy of these sensors be assessed in 
different conditions and in the populations by which they will be used. This thesis 
focuses on the accuracy and utility of physical activity monitors for the purpose of 
developing an AP system that takes into account various metrics of physical activity 
(e.g. HR, EE, etc.) into the control algorithm. 
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2. REVIEW OF THE SCIENTIFIC LITERATURE 
2.1. ACCURACY OF ACTIVITY MONITORS DURING PHYSICAL ACTIVITY 
The scientific literature examining the accuracy of consumer-grade activity 
monitors at measuring EE during physical activity can be divided into six different types 
of activity: walking, running, elliptical exercise, cycling, resistance exercise, and sports 
and sports-related exercise. 
 
2.1.1. Walking 
Twenty-four studies have examined the accuracy of EE measurements from 
consumer-grade activity monitors for walking (27–50). Some of these studies have 
examined accuracy during a combination of activities, but did not report the accuracy of 
the devices tested during individual activities, such as walking (28,30–32,40,41). 
However, many others have reported their findings for accuracy of activity monitors 
during walking (Table 1). Accuracy at a variety of different walking speeds has been 
assessed, with some studies examining accuracy during two or three different walking 
speeds (31,34–36,38,40,44–48), while others have observed accuracy at different 
treadmill inclines (42,49). The majority of these studies have been conducted for 
treadmill walking, while a few studies have also assessed accuracy during overground 
walking (27,50). In addition, two studies have assessed the accuracy of activity monitors 
for walking with weighted bags (38,47). 
Gusmer et al. (33) had 32 healthy adults perform 30 minutes of slow walking 
(avg. speed: 2.5  0.3 mph) and 30 minutes of brisk walking (avg. speed: 3.0  0.4 mph) 
at self-selected walking speeds, while wearing the Fitbit Ultra (Fitbit, Inc., California, 
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USA) at the hip. The Fitbit Ultra underestimated EE during both slow walking (P>0.05) 
and brisk walking (P<0.05) compared to indirect calorimetry. The Fitbit Ultra displayed a 
moderate relationship with the indirect calorimeter during slow walking (r=0.69, 
P<0.001) and a strong relationship with the indirect calorimeter during brisk walking 
(r=0.94, P<0.001). The Fitbit Ultra also displayed wider 95% limits of agreement (LoA) 
during slow walking compared to brisk walking. This study demonstrated greater error 
and underestimation in EE measurements by the Fitbit Ultra at faster walking speeds 
(33). 
Wahl et al. (39) assessed the accuracy of 10 activity monitors during two different 
walking speeds. Twenty healthy adults walked at 2.7 mph and 4.3 mph on a treadmill 
for 5 minutes at each speed, while wearing various activity monitors: Beurer AS80 
(Beurer GmbH, Ulm, Germany), Fitbit Charge (Fitbit, Inc., California, USA), Fitbit 
Charge HR (Fitbit, Inc., California, USA), Garmin Forerunner 920XT (Garmin 
International, Inc., Kansas, USA), Garmin vívoactive (Garmin International, Inc., 
Kansas, USA), Garmin vívofit (Garmin International, Inc., Kansas, USA), Garmin 
vívosmart (Garmin International, Inc., Kansas, USA), Polar Loop (Polar Electro, 
Kempele, Finland), and Withings Pulse Ox (Withings, Issy-les-Moulineaux, France). One 
of each device was worn on the wrist, while an additional Withings Pulse Ox monitor was 
worn at the hip. All devices overestimated EE while walking at 2.7 mph by 1-83%, 
except for the Garmin Forerunner 920XT and Withings Pulse Ox worn at the hip and at 
the wrist, which underestimated by 27%, 11%, and 10%, respectively. All devices 
overestimated EE while walking at 4.3 mph by 17-54%, except for the Beurer AS80 and 
Garmin Forerunner 920XT, which underestimated by 19% and 17%, respectively. For 
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the 2.7 mph walking speed, the Garmin vívofit (1%), Garmin vívosmart (3%), Garmin 
vívoactive (4%), and Withings Pulse at the hip (-10%) were the only devices to achieve 
a mean relative percentage error (%RE) of 10%. No devices achieved this for the 4.3 
mph walking speed. Similar to the Gusmer et al. (33) study, Wahl et al. observed 
greater error in EE at faster walking speeds in 6 out of the 10 consumer-grade activity 
monitors tested (39). 
Price et al. (48) had subjects walk at three different speeds for 4 minutes each. 
Fourteen healthy adults walked at 1.6, 2.8, and 4.0 mph on a treadmill, while wearing 
the Fitbit One (Fitbit, Inc., California, USA) at the hip and the Garmin vívofit and the 
Jawbone UP (Jawbone, California, USA) on the wrist. The Fitbit One displayed a mean 
overestimation in EE of 2.2 kcal/min across all walking speeds compared to indirect 
calorimetry, while the Garmin vívofit and Jawbone UP displayed an underestimation in 
EE of 1.7 kcal/min and 2.1 kcal, respectively. Bias was greater as walking intensity 
increased for the Fitbit One and Garmin vívofit, but could not be analyzed for the 
Jawbone UP. This study also demonstrated increased error by activity monitors at faster 
walking speeds (48). 
While most studies examine the accuracy of activity monitors at different walking 
speeds on level ground, Alsubheen et al. (42) examined accuracy in EE for walking at 
different inclines. Thirteen healthy adults completed self-paced walking (ranging from 
2.5 to 4.5 mph) at three different inclines (0%, 5%, and 10%), while wearing the Garmin 
vívofit on the wrist. The Garmin vívofit significantly underestimated EE for walking at all 
inclines by 30% compared to indirect calorimetry (P<0.05). The magnitude of 
underestimation displayed by the Garmin vívofit decreased as exercise intensity 
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increased, with the device underestimating by 45%, 30%, and 18% at 0%, 5%, and 10% 
inclinations, respectively. While other studies have demonstrated decreased accuracy 
at faster walking speeds, Alsubheen et al. were able to demonstrate increased accuracy 
in EE measurements for self-paced walking at higher inclines (42). 
Noah et al. (49) also assessed activity monitor accuracy at different inclines. 
Twenty-three healthy adults walked at 3.5 mph for 6-minute bouts at a 0% and 5% 
incline on a treadmill, while wearing the Fitbit (Fitbit, Inc., California, USA) and the 
newer activity monitor, the Fitbit Ultra, at the hip. Both devices significantly 
underestimated EE at both inclines compared to indirect calorimetry (P<0.006). Both 
devices displayed greater %RE at measuring EE for inclined walking (40%) than for 
level walking. A strong intraclass correlation coefficient (ICC) with the indirect 
calorimeter was displayed by the Fitbit (r=0.70-0.72) and Fitbit Ultra (r=0.81-0.83) while 
walking on a 0% and 5% incline. The Fitbit Ultra displayed higher EE values and higher 
ICC than the Fitbit. As opposed to the Alsubheen et al. study (42), this study displayed 
greater error in EE measurements at higher inclines. In addition, this study was able to 
demonstrate improved accuracy in EE measurements by the Fitbit Ultra compared to 
the Fitbit. The improvements in EE accuracy may have been due to hardware upgrades, 
as well as improvements made to the proprietary EE algorithms by the manufacturer 
(49). 
Diaz et al. (37) examined the accuracy of EE measurements by a wrist-worn and 
hip-worn activity monitor. Twenty-three healthy adults walked at 1.9, 3.0, and 4.0 mph 
on a treadmill for 6 minutes each, while wearing the Fitbit Flex (Fitbit, Inc., California, 
USA) at the wrist and the Fitbit One at the hip. The Fitbit Flex underestimated EE for 
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walking at 1.9 mph, while overestimating EE for walking at 3.0 and 4.0 mph compared 
to indirect calorimetry. The Fitbit One underestimated EE for walking at 1.9 and 3.0 mph 
and overestimated EE at 4.0 mph. The greatest difference in EE measurements 
occurred for walking at 3.0 and 4.0 mph by the Fitbit Flex, which overestimated EE by 
52% and 33%, respectively. Between the two devices, the Fitbit One (hip-worn) 
displayed greater accuracy than the Fitbit Flex (wrist-worn) in EE measurements (37). 
Diaz et al. (36) conducted a follow-up study using the same exercise protocol, 
but in addition to having subjects wear the Fitbit Flex on the wrist and Fitbit One at the 
hip, subjects also wore an additional Fitbit One on the upper torso. Thirteen healthy 
females walked at three speeds (1.9, 3.0, and 4.0 mph) on a treadmill for 6 minutes 
each, while wearing the three activity monitors. The Fitbit Flex overestimated EE, while 
the Fitbit One at the hip and upper torso underestimated EE at 1.9 mph compared to 
indirect calorimetry. All three devices overestimated EE at 3.0 and 4.0 mph. The Fitbit 
One at the hip displayed the greatest accuracy in EE measurements during all 3 walking 
speeds compared to indirect calorimetry, with a %RE in EE of -8%, 13%, and 12% at 
1.9, 3.0, and 4.0 mph, respectively. Meanwhile, the Fitbit Flex at the wrist displayed the 
least accuracy in EE, with a %RE of 83%, 68%, and 29% at 1.9, 3.0, and 4.0 mph, 
respectively. With this study, Diaz et al. demonstrated that although the Fitbit One worn 
at the upper torso was less accurate at measuring EE than wearing it at the hip, it was 
still more accurate than measuring EE at the wrist by the Fitbit Flex for walking at 
different speeds (36). 
Sasaki et al. (47) had subjects walk at two different speeds on a 5% incline, as 
well as walk on level ground with weighted bags. Twenty healthy adults walked at 3.0 
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mph and 4.0 mph on a 5% incline and walked while carrying weighted bags (4 lb each) 
for 6-minute bouts, while wearing the Fitbit at the hip. The Fitbit significantly 
underestimated EE by 22% and ~35% while walking at 3.0 mph and 4.0 mph, and 
significantly overestimated EE by ~40% while carrying weighted bags (P<0.05). Since 
the Fitbit was worn at the hip, Sasaki et al. hypothesized that subjects may have 
exacerbated hip movements while carrying the weighted bags in an effort to maintain 
stability while walking, which may have caused the Fitbit to overestimate EE for 
weighted walking (47). 
Studies examining the accuracy of consumer-grade activity monitors for walking 
at 1.5-4.5 mph have determined most activity monitors to display poor accuracy at 
measuring EE (27,31,32,34–38,40–43,46–48), with many activity monitors displaying a 
%RE of >10% (35–37,42) and a mean absolute percentage error (MAPE) of >10% 
(34,38,43,47,50). Activity monitors have been demonstrated to display greater 
inaccuracy at faster walking speeds (28,33,48). Conflicting results have been observed 
in accuracy for walking at different inclines, with Alsubheen et al. (42) displaying greater 
accuracy at higher inclines and Noah et al. (49) displaying decreased accuracy at 
higher inclines. In addition, Diaz et al. demonstrated in two separate studies that a hip-
worn activity monitor was more accurate than a wrist-worn activity monitor at measuring 
EE for walking (36,37). Sasaki et al. observed greater %RE and an overestimation in 
EE for walking with weighted bags, which may have been due to increased hip 
movement required for stability during weighted walking (47). 
 
 
  
13 
2.1.2. Running 
Twenty-three studies have examined the accuracy of EE measurements from 
consumer-grade activity monitors for running (27,28,30–32,34–41,43–52). Some of 
these studies have examined accuracy during a combination of activities, but did not 
report the accuracy of the devices tested during individual activities, such as running 
(28,30–32,40,41). However, many others have reported their findings for accuracy of 
activity monitors during running (Table 2). Accuracy at various running speeds has been 
assessed, with some studies only examining accuracy at one speed (34,36–
38,43,47,49) and others examining multiple running speeds (35,39,44,46,48,51). The 
majority of these studies have been conducted for treadmill running, while a few studies 
have also assessed accuracy during overground running (28,39,50). 
Noah et al. (49) had 23 healthy adults run for 6 minutes at 5.5 mph, while 
wearing the Fitbit and the newer activity monitor, the Fitbit Ultra, at the hip. Both devices 
significantly underestimated EE for running compared to indirect calorimetry (P<0.006). 
A strong ICC with the indirect calorimeter was displayed by the Fitbit Ultra (r=0.87) and 
a moderate ICC was displayed by the Fitbit (r=0.56). The Fitbit Ultra displayed higher 
EE values and higher ICC than the Fitbit. This study was able to demonstrate improved 
accuracy in EE measurements by the Fitbit Ultra compared to the Fitbit for running. The 
improvements in EE accuracy may have been due to hardware upgrades, as well as 
improvements made to the proprietary EE algorithms by the manufacturer (49). 
Price et al. (48) had subjects run on a treadmill at three different speeds. 
Fourteen healthy adults ran at 5.0, 6.2, and 7.5 mph for 4 minutes at each speed, while 
wearing the Fitbit One at the hip and the Garmin vívofit and the Jawbone UP at the 
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wrist. The Fitbit One and Jawbone UP displayed a mean overestimation in EE of 3.6 
kcal/min and 20.6 kcal, respectively, across all running speeds compared to indirect 
calorimetry, while the Garmin vívofit displayed an underestimation in EE of 1.5 kcal/min. 
Bias was greater as running intensity increased for the Fitbit One, but not the Garmin 
vívofit. The Jawbone UP displayed greater bias during running (20.6 kcal) compared to 
walking (-2.1 kcal), which also indicated greater error at higher exercise intensities. This 
study was essentially able to demonstrate increased error in EE measurements by two 
out three activity monitors tested at faster running speeds (48). 
Kendall et al. (52) had 50 subjects perform a graded maximal test on a treadmill, 
while wearing the Basis B1 (Intel Corporation, California, USA) and Fitbit Flex on the 
wrist, the Jawbone UP and OMRON HJ-321 (OMRON Corporation, Kyoto, Japan) on 
the hip, and the Polar FT7 (Polar Electro, Kempele, Finland) at the chest. Subjects 
began running at a self-selected speed and 0% incline and then incline was increased 
by 2% every 2 minutes until exhaustion. The Basis B1, Fitbit Flex, Jawbone UP24, and 
Polar FT7 all significantly overestimated EE, while the OMRON HJ-321 significantly 
underestimated EE during the graded maximal test compared to indirect calorimetry 
(P<0.05). The Polar FT7 (r=0.74) and Jawbone UP (r=0.75) displayed a moderate ICC 
with indirect calorimetry, while the Basis B1 (r=0.80), Fitbit Flex (r=0.81) and OMRON 
HJ-321 (r=0.83) displayed a strong ICC for the maximal test. When the ICC of devices 
worn by subjects that ran at slower speeds and lower inclines was compared to those 
who ran at higher speeds and reached a higher incline, the activity monitors displayed 
lower ICC at higher speeds and inclines compared to slower speeds and lower inclines, 
indicating decreased EE measurement accuracy at higher exercise intensities (52). 
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Roos et al. (51) had 20 healthy adults run at 30%, 50%, 70%, 90%, and 110% of 
VO2 peak on a treadmill, while wearing the Garmin Forerunner 920XT, Polar V800 
(Polar Electro, Kempele, Finland), and Suunto Ambit2 (Suunto, Vantaa, Finland) on the 
wrists. Subjects ran for 10-minute bouts at 30%, 50%, and 70% of VO2 peak (low- to 
moderate-intensity) and ran for 90 seconds at 90% and 110% of VO2 peak (high-
intensity). The Garmin Forerunner 920XT underestimated EE (P=0.01) and the Suunto 
Ambit2 significantly overestimated EE (P=0.002) for running at 30% of VO2 peak. The 
Suunto Ambit2 also significantly overestimated EE for running at 50% of VO2 peak 
(P=0.003). For anaerobic running at 90% and 110% of VO2 peak, all devices 
significantly underestimated EE compared to indirect calorimetry (P<0.001). Similar to 
the findings of previously discussed studies, this underestimation in EE increased as 
running intensity increased (51). 
Dondzila and Garner (35) examined the accuracy of a wrist-worn and ear-worn 
activity monitor. Nineteen healthy adults completed 5-minute bouts of running at 5.0 
mph and 6.0 mph on a treadmill, while wearing the Fitbit Charge on the wrist and Jabra 
Sport Pulse Wireless Earbuds (GN Netcom, Ballerup, Denmark) in the ears. The Fitbit 
Charge and Jabra earbuds significantly underestimated EE by 14% and 16%, 
respectively, compared to indirect calorimetry during the 5.0 mph running speed 
(P<0.05). Both the Fitbit Charge and Jabra earbuds displayed a greater underestimation 
in EE at the 6.0 mph running speed (Fitbit: -23%, Jabra: -23%) compared to the 5.0 
mph running speed (Fitbit: -14%, Jabra: -16%). The Jabra earbuds displayed greater 
variability than the Fitbit Charge at both running speeds. The Jabra earbuds were not 
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more accurate than the wrist-worn Fitbit Charge at measuring EE and both devices 
displayed greater error in EE measurements at faster running speeds (35). 
Diaz et al. (37) examined the accuracy of a wrist-worn and hip-worn activity 
monitor for running. Twenty-three healthy adults ran at a speed of 5.2 mph on a 
treadmill for 6 minutes, while wearing the Fitbit Flex at the wrist and the Fitbit One at the 
hip. During the run, all devices overestimated EE compared to indirect calorimetry. 
Between the two devices, the Fitbit One (hip-worn) displayed greater accuracy than the 
Fitbit Flex (wrist-worn) at measuring EE (37). 
In a follow-up study, Diaz et al. (36) had subjects wear the Fitbit Flex on the wrist 
and Fitbit One at the hip, as well as an additional Fitbit One on the upper torso. Thirteen 
healthy females ran at 5.2 mph on a treadmill for 6 minutes, while wearing the three 
devices. The Fitbit One at the hip (-3%) displayed greater accuracy in EE 
measurements for running than the Fitbit One at the upper torso (11%) and the Fitbit 
Flex (25%) compared to indirect calorimetry. Diaz et al. demonstrated that although the 
Fitbit One worn at the upper torso was less accurate at measuring EE than wearing it at 
the hip, it was still more accurate than measuring EE at the wrist by the Fitbit Flex for 
running (36). 
Studies examining the accuracy of consumer-grade activity monitors for running 
at 5.0-8.5 mph have determined most activity monitors to be inaccurate at measuring 
EE (27,28,34,35,38,39,43–48,50,51), with some activity monitors displaying a %RE of 
>10% (35,43) and a MAPE of >10% (34,38,43,50,51). Activity monitors have been 
demonstrated to display greater inaccuracy at faster running speeds, including up to 
maximal-intensity exercise (35,48,51,52). In addition, Diaz et al. demonstrated in two 
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separate studies that a hip-worn activity monitor was more accurate than a wrist-worn 
activity monitor at measuring EE for running, while Dondzila and Garner did not observe 
greater accuracy in EE measurements by an ear-worn activity monitor compared to a 
wrist-worn monitor (35–37). 
 
2.1.3. Elliptical Exercise 
Three studies have incorporated elliptical exercise into their physical activity 
protocol for the assessment of EE accuracy in consumer-grade activity monitors 
(30,32,45). However, two of the three studies only examined accuracy in EE during all 
activities combined and did not report accuracy of the devices during individual types of 
activity (30,32). As a result, the accuracy of these devices at measuring EE during the 
different activities performed, such as elliptical exercise, is unknown. 
However, Stackpool et al. (45) assessed and reported the accuracy of five 
different activity monitors at measuring EE during 20 minutes of self-paced exercise on 
an elliptical cross-trainer. Twenty healthy adults wore the Adidas miCoach (Adidas AG, 
Herzogenaurach, Germany), BodyMedia FIT CORE (BodyMedia, Pennsylvania, USA), 
Fitbit Ultra, Jawbone UP, and Nike FuelBand (Nike, Inc., Oregon, USA) while 
performing elliptical exercise. Devices were worn according to manufacturers’ 
instructions, but the exact wear location for each device was not reported. The Adidas 
miCoach was unable to detect elliptical exercise, and therefore, no data was reported 
for this device. The BodyMedia FIT CORE and the Nike FuelBand significantly 
underestimated EE by 20% and 27%, respectively, compared to indirect calorimetry 
(P<0.05). A weak relationship was observed between the devices and indirect 
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calorimetry, with Pearson correlation coefficients of 0.47, 0.41, 0.40, and 0.08 displayed 
for the BodyMedia FIT CORE, Fitbit Ultra, Jawbone UP, and Nike FuelBand, 
respectively. The NikeFuel Band displayed the greatest underestimation and the 
smallest correlation with indirect calorimetry out of all of the devices assessed (45). 
 
2.1.4. Cycling 
Eleven studies have assessed the accuracy of consumer-grade activity monitors 
for measuring EE during cycling (27,28,30–32,38,43,46,47,50,53). Seven of these 
studies have examined and reported the accuracy of devices during different types of 
activities, while the remaining four only examined accuracy in EE during all activities 
performed combined and did not report accuracy during individual activities, such as 
cycling (28,30–32). 
Nelson et al. (50) had 16 healthy adults cycle for 5 minutes at a self-selected 
intensity on a cycle ergometer, while wearing the Fitbit Flex and Jawbone UP24 
(Jawbone, California, USA) on the wrist and the Fitbit One and Fitbit Zip (Fitbit, Inc., 
California, USA) on the hip. All devices significantly underestimated EE during cycling 
by 37-59% (P=0.025 – <0.001). All devices displayed a high MAPE during cycling 
compared to indirect calorimetry. The MAPE in EE measurements during cycling were 
43%, 44%, 46%, and 57% for the Fitbit One, Fitbit Flex, Fitbit Zip, and Jawbone UP24, 
respectively (50). 
Sasaki et al. (47) examined the accuracy of the Fitbit at measuring EE during 6 
minutes of steady-state cycling at 50 W on a cycle ergometer in 20 healthy adults. The 
Fitbit significantly underestimated EE by 104% compared to indirect calorimetry 
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(P<0.05), while a %RE of approximately 40% was demonstrated by the Fitbit during 
other activities, such as activities of daily living (ADL), ambulatory activities, and sports 
(47). 
Chowdhury et al. (38) had 30 healthy adults perform 10 minutes of steady-state 
cycling on a cycle ergometer, with females cycling at 75 W and males cycling at 100 W. 
All subjects wore the Apple Watch (Apple Inc., California, USA), Fitbit Charge HR, 
Jawbone UP24, and Microsoft Band (Microsoft Corporation, Washington, USA) on the 
wrists while cycling. All devices displayed high MAPE compared to indirect calorimetry 
(20-82%). The MAPE in EE measurements during cycling was 20%, 38%, 53%, and 
82% for the Apple Watch, Microsoft Band, Fitbit Charge HR, and Jawbone UP24, 
respectively (38). 
Instead of having subjects cycle at a single intensity, Shcherbina et al. (46) had 
subjects complete both low- and high-intensity cycling. Sixty healthy adults performed 5 
minutes of low-intensity (50-100 W) cycling and 5 minutes of high-intensity (80-225 W) 
cycling on a cycle ergometer, while wearing five wrist-worn activity monitors: Apple 
Watch, Basis Peak (Intel Corporation, California, USA), Fitbit Surge (Fitbit, Inc., 
California, USA), Microsoft Band, and PulseOn (PulseOn, Espoo, Finland). EE data 
from both cycling intensities was pooled together. The median absolute percentage 
error ranged from ~25-100% on all devices. The Fitbit Surge displayed the lowest 
median absolute percentage error (~25%), while the PulseOn displayed the highest 
(~100%) (46). 
Pribyslavska et al. (43) assessed the accuracy of EE measurements during 
moderate- and vigorous-intensity cycling. Thirty-four healthy adults completed 10-
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minute bouts of cycling at moderate-intensity (40-59% of heart rate reserve [HRR]) and 
vigorous-intensity (60-84% of HRR) on a cycle ergometer, while wearing the Fitbit 
Surge and Garmin vívofit on the wrists. Both activity monitors underestimated EE for 
cycling at moderate-intensity (Fitbit: 20%, Garmin: 6%) and vigorous-intensity (Fitbit: 
23%, Garmin: 0%). The Fitbit Surge displayed a MAPE of 28% for both moderate- and 
vigorous-intensity cycling, while the Garmin vívofit displayed a MAPE of 19% for 
moderate-intensity cycling and 16% for vigorous-intensity cycling (43). 
Woodman et al. (27) conducted the only study to assess the accuracy of activity 
monitors during both indoor and outdoor cycling. Twenty-five healthy adults completed 5 
minutes of indoor cycling on a cycle ergometer at 100 W and 26 adults completed 5 
minutes of cycling outdoors at a self-selected speed, while wearing the Basis Peak and 
Garmin vívofit on the wrists and three Withings Pulse (Withings, Issy-les-Moulineaux, 
France) activity monitors (one on shirt collar, one on hip, and one on wrist). All devices 
significantly underestimated EE during both indoor and outdoor cycling compared to 
indirect calorimetry (P<0.05). The Basis Peak displayed the least underestimation for 
indoor (7.0  5.1 kcal/min) and outdoor cycling (5.4  3.5 kcal/min), while the Withings 
Pulse on the wrist displayed the greatest underestimation for both indoor (1.2  2.0 
kcal/min) and outdoor cycling (1.2  2.0 kcal/min) compared to indirect calorimetry 
(Indoor: 9.2  1.2 kcal/min, Outdoor: 8.7  2.6 kcal/min). There was no significant 
difference in EE measurements from the Withings Pulse devices placed at the collar, 
hip, or wrist during indoor cycling (P<0.05). However, EE measurements from the 
Withings Pulse at the shirt collar and the hip were both significantly higher than the 
device at the wrist (P<0.001), but not significantly different from each other (P>0.05) 
  
21 
during outdoor cycling, indicating greater accuracy by the Withings Pulse at measuring 
EE at the shirt collar and hip than the wrist (27). 
While most studies have examined the accuracy of activity monitors during 
steady-state cycling, Boudreaux et al. (53) completed a study assessing EE accuracy 
during a graded exercise test. Fifty healthy adults performed a graded exercise test on a 
cycle ergometer, while wearing seven different activity monitors: Apple Watch 2 (Apple 
Inc., California, USA), Fitbit Blaze (Fitbit, Inc., California, USA), Fitbit Charge 2 (Fitbit, 
Inc., California, USA), Garmin vívosmart HR (Garmin International, Inc., Kansas, USA), 
Polar A360 (Polar Electro, Kempele, Finland), Polar H7 (Polar Electro, Kempele, 
Finland), and TomTom Touch (TomTom International, Amsterdam, Netherlands). 
Subjects wore six devices on the wrists (three per wrist) and the Polar H7 on the chest. 
They began cycling at 50 rpm and 50 W and every 2 minutes the power output was 
increased by 25 W until exhaustion. EE measurements from all devices, except the 
Garmin vívosmart HR, were significantly different from indirect calorimetry (P<0.05). All 
the devices tested displayed weak ICC with the indirect calorimeter (r=0.18-0.41). All 
devices also displayed high MAPE compared to indirect calorimetry (21-75%). The 
Apple Watch 2 displayed the lowest MAPE (21%), while the Fitbit Charge 2 displayed 
the highest MAPE (75%). The Fitbit Blaze and Fitbit Charge 2 underestimated EE in 
84% and 80% of subjects, respectively, while the remaining five devices overestimated 
EE in 52-98% of subjects during cycling (53). 
Twenty-one different consumer-grade activity monitors have been tested for 
accuracy in EE during cycling. All devices tested by Nelson et al., Chowdhury et al., 
Pribyslavska et al., and Boudreaux et al. displayed high MAPE values, ranging from 16-
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82% (38,43,50,53). While Sasaki et al. and Shcherbina et al. did not report MAPE 
values for the activity monitors tested, Sasaki et al. reported a mean underestimation in 
EE by 104% for the Fitbit and Shcherbina et al. reported median absolute percentage 
errors ranging from ~25-100% for the devices tested (46,47). Woodman et al. observed 
a significant underestimation in EE during both indoor and outdoor cycling by three 
different activity monitors and greater accuracy in EE measured at the shirt collar and 
hip compared to the wrist during outdoor cycling (27). In addition, two studies assessed 
the accuracy of the Jawbone UP24 during cycling, and in both studies, this device 
displayed a higher MAPE (57-82%) than any of the other activity monitors tested in 
each study (38,50). 
 
2.1.5. Resistance Exercise 
Although the Canadian Society for Exercise Physiology, American College of 
Sports Medicine, Diabetes Canada, and ADA have all recommended performing 
resistance exercise on at least 2 days of the week, only two studies have examined the 
accuracy of consumer-grade activity monitors during resistance exercise (15,16,40,53–
55). 
Boudreaux et al. (53) had subjects perform 3 circuits of 10 repetitions of leg curls, 
chest press, leg extensions, and latissimus dorsi pulldowns, while wearing seven 
different activity monitors. Fifty healthy adults wore the Apple Watch 2, Fitbit Blaze, 
Fitbit Charge 2, Garmin vívosmart HR, Polar A360, and TomTom Touch on the wrists 
and the Polar H7 on the chest. All of the devices tested displayed weak ICC with the 
indirect calorimeter (r=0.02-0.18). All devices displayed high MAPE compared to indirect 
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calorimetry (43-57%). The Apple Watch displayed the lowest MAPE (43%), while the 
Garmin vívosmart HR displayed the highest MAPE (57%). All devices overestimated EE 
in 60-90% of subjects during resistance exercise (53). 
On the other hand, Bai et al. (40) conducted a study where they aimed to 
simulate real-world conditions by allowing subjects to perform 25 minutes of resistance 
exercise using self-selected exercises, weights, sets, and repetitions. Subjects 
performed any combination of 12 different exercises: rotary torso, abdominal crunch, 
lower back, vertical traction, shoulder press, arm curl, arm extension, leg press, leg curl, 
leg extension, multi-hip, and chest press. Fifty-two healthy adults performed all 
exercises while wearing the Fitbit Flex, Jawbone UP24, Misfit Shine (Misfit, California, 
USA), and Nike+ FuelBand SE (Nike, Inc., Oregon, USA) on the wrists. The Fitbit Flex 
(25.5 kcal) and Nike+ FuelBand SE (26.3 kcal) displayed the smallest mean bias 
compared to indirect calorimetry, followed by the Misfit Shine (30.8 kcal) and Jawbone 
UP24 (47.2 kcal). All devices underestimated EE during resistance exercise. The lowest 
MAPE was displayed by the Fitbit Flex (32%) and the highest MAPE was displayed by 
the Jawbone UP24 (53%) (40). 
In total, 11 different consumer-grade activity monitors were assessed for 
accuracy in EE during resistance exercise between both studies, and all devices tested 
displayed high MAPE, ranging from 32-57%. However, Bai et al. reported that all 
devices tested underestimated EE, while Boudreaux et al. observed an overestimation 
in EE in 60-90% of subjects during resistance exercise (40,53). 
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2.1.6. Sports and Sports-Related Exercise 
Four studies have examined the accuracy of consumer-grade activity monitors 
during sports or sports-related exercise (30,45,47). Lee et al. (30) had subjects play 
basketball and tennis during a 69-minute exercise protocol, but did not report the 
accuracy of devices during individual activities. As a result, the accuracy of the devices 
tested in this study during basketball and tennis are unknown. 
However, Sasaki et al. (47) examined and reported the accuracy of the Fitbit 
while subjects performed 6 minutes of basketball, golf, and tennis, for a total time of 18 
minutes. The Fitbit was worn at the hip by 20 healthy adults while performing the 
different sports. The Fitbit displayed an overall underestimation in EE during sports, with 
a mean bias of -2.1 kcal/6 min (95% LoA: -26.0 to 22.0 kcal/6 min) compared to indirect 
calorimetry. However, for individual sports, the Fitbit underestimated EE during tennis 
by ~15%, while overestimating EE during basketball by ~20%, and displaying almost no 
mean difference (~0%) in EE during golf (47). 
Wahl et al. (39) had 20 healthy adults perform 5 minutes of intermittent running 
simulating a soccer game, while wearing various activity monitors: Beurer AS80, Fitbit 
Charge, Fitbit Charge HR, Garmin Forerunner 920XT, Garmin vívoactive, Garmin 
vívofit, Garmin vívosmart, Polar Loop, and Withings Pulse Ox. One of each device was 
worn on the wrist, while an additional Withings Pulse Ox monitor was worn at the hip. 
The Garmin vívosmart, Fitbit Charge, Fitbit Charge HR, and Polar Loop all 
overestimated EE by 1-49% during the intermittent running, while the Beurer AS80, 
Garmin Forerunner 920XT, Garmin vívoactive, Garmin vívofit, and Withings Pulse Ox at 
the hip and wrist all underestimated EE by 2-26% compared to indirect calorimetry. The 
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Garmin vívoactive (-1%), Fitbit Charge (2%), Garmin vívosmart (2%), Polar Loop (6%), 
and Garmin Forerunner 920XT (-9%) were the only devices to display a %RE of 10%. 
The Garmin vívofit (r=0.54), Fitbit Charge (r=0.58), and Garmin vívoactive (r=0.74) all 
displayed a moderate ICC with indirect calorimetry. All other devices displayed poor ICC 
(r=0.00-0.43) with indirect calorimetry for intermittent running (39). 
Meanwhile, Stackpool et al. (45) had subjects perform 20 minutes of basketball-
related activities, including agility ladder drills, basketball free throws, T drills, and a 
basketball half-court lay-up drill, while wearing the Adidas miCoach, BodyMedia FIT 
CORE, Fitbit Ultra, Jawbone UP, and Nike FuelBand. The devices were worn by 20 
healthy adults and were worn according to manufacturers’ instructions, but the exact 
wear location for each device was not reported. All of the devices tested significantly 
underestimated EE by 14-60% compared to indirect calorimetry (P<0.05). The %RE 
was -14%, -17%, -18%, -30%, and -60% for the Nike FuelBand, Fitbit Ultra, BodyMedia 
FIT CORE, Jawbone UP, and Adidas miCoach, respectively. The Fitbit Ultra (r=0.67), 
Jawbone UP (r=0.65), Adidas miCoach (r=0.57), and BodyMedia FIT CORE (r=0.56) all 
displayed moderate relationships with indirect calorimetry, while the Nike FuelBand 
(r=0.47) displayed a weak relationship (45). 
Of the 15 consumer-grade activity monitors tested, 11 devices displayed a mean 
underestimation in EE during sports and sports-related exercise (39,45,47). However, 
while Sasaki et al. examined an overestimation in EE during basketball by the Fitbit, 
Stackpool et al. observed an underestimation in EE during basketball-related activities 
by five different activity monitors (45,47). 
 
  
26 
2.2. ACCURACY OF ACTIVITY MONITORS DURING DAILY LIVING AND 
SEDENTARY ACTIVITIES 
2.2.1. Activities of Daily Living 
Seven studies have assessed the accuracy of consumer-grade activity monitors 
at measuring EE during activities of daily living (ADL) (27,31,32,38,41,47,50). However, 
only five of these studies have examined and reported the accuracy of devices during 
individual types of activities, including ADL. 
Nelson et al. (50) had subjects perform eight ADL (standing, dusting, sweeping, 
vacuuming, folding laundry, making bed, picking up items from floor, and gardening) for 
5 minutes each, while wearing the Fitbit Flex, Fitbit One, Fitbit Zip, and Jawbone UP24. 
Fifteen healthy adults performed the activities, while wearing the Fitbit Flex and 
Jawbone UP24 on the wrists and the Fitbit One and Fitbit Zip on the hip. All of the 
devices significantly underestimated EE during ADL by 27-34% (P<0.001), except the 
Fitbit Flex, which was not significantly different from indirect calorimetry. All devices 
displayed high MAPE during ADL. The MAPE in EE measurements during ADL were 
21%, 27%, 35%, and 36% for the Fitbit Flex, Fitbit One, Jawbone UP24, and Fitbit Zip 
respectively (50). 
Chowdhury et al. (38) had 30 healthy adults complete 15 minutes of ADL, 
including loading and unloading a dishwasher, sweeping, and self-paced ascending and 
descending of stairs, while wearing the Apple Watch, Fitbit Charge HR, Jawbone UP24, 
and Microsoft Band at the wrists. MAPE in EE ranged from 15-62% across all devices 
during all three activities. The Fitbit Charge HR displayed the lowest MAPE during the 
loading and unloading of a dishwasher (23%) and walking up and down stairs (15%), 
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while the Apple Watch displayed the lowest MAPE during sweeping (30%). The 
Microsoft Band displayed the highest MAPE in EE during all three activities, with a 
MAPE of 54%, 45%, and 62% during the loading and unloading of a dishwasher, 
sweeping, and walking up and down stairs, respectively (38). 
Bai et al. (41) had 39 healthy adults perform 25 minutes of ADL, including folding 
laundry, sweeping, moving light boxes, stretching, and slow walking, while wearing the 
Apple Watch and Fitbit Charge HR on the wrist. The Apple Watch displayed a small 
overestimation in EE by 4%, while the Fitbit Charge HR displayed a large 
underestimation in EE by 60% compared to indirect calorimetry. Although Chowdhury et 
al. (38) observed a MAPE of 29-34% by the Apple Watch, Bai et al. observed a lower 
overall MAPE of 23% by this device during ADL. On the other hand, Chowdhury et al. 
reported that the Fitbit Charge HR displayed the lowest MAPE (15-23%) during two out 
of three ADL performed compared to three other activity monitors, while Bai et al. 
observed a high overall MAPE of 61% by the Fitbit Charge HR during ADL. The MAPE 
observed by Bai et al. for the Fitbit Charge HR (61%) was over two times greater than 
the MAPE displayed by the Apple Watch (23%). In addition, the Fitbit Charge HR 
(r=0.41, P<0.05) displayed a weaker correlation with the indirect calorimeter than the 
Apple Watch (r=0.66, P<0.01) (41). 
Woodman et al. (27) had subjects perform 15 minutes of ADL. Twenty-five 
healthy adults folded clothes, swept the floor, and ascended and descended stairs, 
while wearing the Basis Peak and Garmin vívofit on the wrists and three Withings Pulse 
activity monitors (one on shirt collar, one on hip, and one on wrist). All devices 
significantly underestimated EE during all ADL compared to indirect calorimetry 
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(P<0.05), except for the Basis Peak, which overestimated EE for walking up and down 
stairs. All devices reported mean EE as 2.0-2.8 kcal/min for folding clothes and 
sweeping, while the indirect calorimeter reported mean kcal as 3.1 and 4.2 kcal/min for 
folding clothes and sweeping, respectively. For ascending and descending stairs, the 
indirect calorimeter reported mean EE as 9.1 kcal/min, while the EE measurements 
from the devices ranged from 3.9 kcal/min by the Withings Pulse on the wrist to 10.3 
kcal/min by the Basis Peak. During all ADL, EE measurements from the Withings Pulse 
at the shirt collar and the hip were both significantly different than the device at the wrist 
(P<0.001), but not significantly different from each other (P>0.05) (27). 
Sasaki et al. (47) had 20 healthy adults perform 30 minutes of ADL, including 
dusting, gardening, laundry, raking, and vacuuming for 6 minutes each, while wearing 
the Fitbit at the hip. The Fitbit displayed an overall underestimation in EE during ADL, 
with a mean bias of -3.1 kcal/6 min (95% LoA: -11.0 to 5.2 kcal/6 min) compared to 
indirect calorimetry. Underestimation in EE occurred during all activities, except for 
dusting, which displayed an overestimation in EE measurements. Bland-Altman plots 
revealed narrower 95% LoA for ADL (difference: 16.2 kcal) compared to ambulatory 
activities (difference: 47.0 kcal) and sports (difference: 48.0 kcal) (47). 
Across these five studies, 11 different activity monitors were assessed for 
accuracy in EE during ADL. Seven out of 10 devices underestimated EE during ADL 
(27,38,41,47,50). Bai et al. (41) observed a lower MAPE in EE measurements by the 
Apple Watch and a higher MAPE by the Fitbit Charge HR compared to Chowdhury et al. 
(38). Woodman et al. (27) examined a significant difference in EE reported by devices 
worn at the shirt collar and hip compared to the wrist, but all devices were still 
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significantly different from indirect calorimetry, regardless of device wear location. In 
addition, Sasaki et al. (47) observed narrower 95% LoA for the Fitbit during ADL 
compared to ambulatory activities and sports, indicating greater accuracy in EE 
measurements by the Fitbit during ADL compared to the other activities. 
 
2.2.2. Sedentary Activities 
In addition to assessing the accuracy of different consumer-grade activity 
monitors during exercise and ADL, five studies have also examined accuracy during 
various sedentary activities. Two studies only examined accuracy in EE during all 
activities performed combined and did not report accuracy of the devices tested during 
individual types of activity. Consequently, the accuracy of these devices at measuring 
EE during different activities, such as sedentary activities, is unknown. 
Nelson et al. (50) had 10-30 healthy adults perform different sedentary activities, 
including lying down (n=30), computer use (n=15), watching television (n=15), writing 
(n=10), playing cards (n=10), and reading (n=10), while wearing the Fitbit Flex and 
Jawbone UP24 on the wrist and the Fitbit One and Fitbit Zip on the hip. All activities 
were performed for 5 minutes each, with the exception of lying, which was performed for 
10 minutes. The Jawbone UP24 significantly underestimated EE by 8% (P=0.013) 
compared to indirect calorimetry. The MAPE in EE measurements during sedentary 
activities were 13%, 14%, 16%, and 17% for the Fitbit One, Fitbit Flex, Fitbit Zip, and 
Jawbone UP24, respectively. All activity monitors had the lowest MAPE during 
sedentary activities (13-17%) compared to ADL (21-36%) and ambulatory activities (16-
36%) (50). 
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Bai et al. (40) assessed the accuracy of EE measurements during 20 minutes of 
sedentary activities, including reading, using a cell phone, typing, watching videos, and 
listening to music/radio. Fifty-two healthy adults completed the activities while wearing 
the Fitbit Flex, Jawbone UP24, Misfit Shine, and Nike+ FuelBand SE on the wrists. The 
Fitbit Flex (5.5 kcal) and Misfit Shine (5.7 kcal) displayed the smallest mean bias, 
followed by the Nike+ FuelBand SE (6.5 kcal) and Jawbone UP24 (11.0 kcal) compared 
to indirect calorimetry. All devices underestimated EE during sedentary activities. MAPE 
was lowest for the Misfit Shine (18%) and Nike+ FuelBand SE (20%) during sedentary 
activities compared to indirect calorimetry (40). 
Bai et al. (41) completed a follow-up study where subjects also completed 20 
minutes of sedentary activities, such as working on a computer, reading, and using a 
cell phone. In this study, they assessed the accuracy of the Apple Watch and Fitbit 
Charge HR at measuring EE at the wrist in 39 healthy adults. As opposed to their 
previous study, Bai et al. observed an overestimation in EE by both devices during 
sedentary activities compared to indirect calorimetry in this study, with the Apple Watch 
overestimating by 9% and the Fitbit Charge HR overestimating by 21%. Both devices 
displayed a high MAPE (Apple: 22%, Fitbit: 35%) and a weak relationship with indirect 
calorimetry, with Pearson correlation coefficients of 0.45 (P<0.01) and 0.40 (P<0.05) for 
the Apple Watch and Fitbit Charge HR, respectively (41). 
In total, eight consumer-grade activity monitors were assessed for accuracy in 
EE during sedentary activities across three different studies, with five of the eight 
devices displaying an underestimation in EE (40,41,50). In addition, Nelson et al. 
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observed the lowest MAPE in EE measurements during sedentary activities compared 
to ADL and ambulatory activities (50). 
 
2.3. ACCURACY OF ACTIVITY MONITORS IN INDIVIDUALS WITH DIABETES 
Although no studies to date have assessed the accuracy of consumer-grade 
activity monitors exclusively in individuals with T1D, one study examined the accuracy 
of consumer-grade and research-grade activity monitors in a combination of individuals 
with and without T1D, while another study assessed the accuracy of research-grade 
activity monitors in individuals with T1D and type 2 diabetes (T2D). 
Yavelberg et al. (56) had 8 individuals with T1D and 17 individuals without T1D 
perform 40 minutes of steady-state exercise on a treadmill at 50% of their maximum 
volume of oxygen consumption (VO2 max) and a 40-minute exercise circuit ranging from 
50-100% of VO2 max. The exercise circuit involved performing variations of high knees, 
squats with a medicine ball, jumping jacks, push-ups, and forearm planks. All subjects 
wore the Metria IH1 arm patch (Avery Dennison Corporation, California, USA) 
(research-grade) and a subset of subjects also wore the Garmin vívofit 2 (n=5-7) 
(consumer-grade) and Mio Fuse (PAI Health Inc., British Columbia, Canada) (n=5-6) 
(consumer-grade) during exercise. The Metria IH1 displayed a mean bias of 0.3 
kcal/min (95% LoA: -2.9 to 3.5 kcal/min) during the steady-state exercise compared to 
indirect calorimetry. During the moderate-to-vigorous intensity (50-75% VO2 max) 
portion of the circuit, the Metria IH1 displayed a mean bias of 0.6 kcal/min (95% LoA: -
2.6 to 3.9 kcal/min), while displaying a mean bias of -1.8 kcal/min (95% LoA: -7.2 to 3.7 
kcal/min) during the vigorous-to-maximum intensity (75-100% VO2 max) portion of the 
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circuit. The Metria IH1 displayed a 4% and 6% overestimation in EE during the steady-
state exercise and moderate-to-vigorous intensity portion of the exercise circuit, 
respectively, and displayed a 13% underestimation in EE during the vigorous-to-
maximum intensity portion of the circuit (P<0.001). The Garmin vívofit 2 underestimated 
EE during both the steady-state exercise (P<0.001) and the exercise circuit (P>0.05) 
compared to indirect calorimetry, while the Mio Fuse overestimated during both types of 
exercise (P>0.05) (56). 
Machac et al. (57) assessed the accuracy of two research-grade activity monitors 
in individuals with T1D and T2D while walking on a treadmill. Nineteen adults with T1D 
or T2D walked for 15-minute bouts at 1.9, 2.5, and 3.1 mph and 0%, 0%, and 5% 
incline, respectively, while wearing the OMRON HJ-720 (OMRON Corporation, Kyoto, 
Japan) and the SenseWear Armband Pro3 (BodyMedia, Pennsylvania, USA). The 
OMRON HJ-720 and SenseWear Armband Pro3 both displayed an overestimation in 
EE by 71% and 81% during level walking at 1.9 mph and by 76% and 78% for level 
walking at 2.5 mph, respectively. During higher intensity walking at 3.1 mph and 5% 
incline, the OMRON HJ-720 and SenseWear Armband Pro3 both displayed an 
underestimation in EE by 7% and 8%, respectively (57). 
The studies conducted by Yavelberg et al. (56) and Machac et al. (57) are the 
only studies to have assessed the accuracy in EE by activity monitors in individuals with 
T1D. Yavelberg et al. observed increased error in EE measurements at higher exercise 
intensities by the Metria IH1, which is consistent with findings from studies performed 
with consumer-grade activity monitors in healthy adults (51,52). However, Machac et al. 
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displayed greater accuracy in EE at a higher walking intensity, which is contradictory to 
the findings from studies conducted in healthy adults (28,33,48,49). 
 
2.4. SUMMARY 
Overall, studies examining the accuracy of consumer-grade activity monitors 
found most devices to be inaccurate at measuring EE during various types of exercise, 
ADL, and sedentary activities (27–29,33–35,38,39,42–48,50,51,53). In most of these 
studies, activity monitors displayed a %RE of >10% (35–37,42,45,47) and a MAPE of 
>10% (34,38,40,41,43,47,50,51,53). Many studies also discovered that as exercise 
intensity increased, accuracy of EE measurements by activity monitors decreased 
(28,33,35,48,49,51,52). 
Although a variety of studies have been conducted to assess the accuracy of 
consumer-grade activity monitors, more research in this field is still needed. Many 
different activity monitors have already been tested, but new models of activity monitors 
are being released to the consumer market every year. These new devices also need to 
be assessed for accuracy in EE measurements and other physiological metrics. The 
majority of the existing studies conducted in this field focus on the accuracy of activity 
monitors during steady-state walking and running, while only a few studies have 
examined accuracy during other forms of physical activity. More studies need to be 
conducted to assess the accuracy of activity monitors during common forms of physical 
activity, such as elliptical exercise, cycling, resistance exercise, and sports. In addition, 
almost all of the studies conducted to date have examined the accuracy of activity 
monitors in healthy adults, with only two studies including individuals with T1D as 
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subjects. However, even within those two studies, data from individuals with and without 
T1D were pooled together by Yavelberg et al. (56), while Machac et al. (57) only 
assessed the accuracy of research-grade activity monitors in individuals with T1D and 
T2D, but did not assess any consumer-grade monitors. Research needs to be 
conducted to assess the accuracy of consumer-grade activity monitors exclusively in 
individuals with T1D, as well as in other non-healthy populations.  
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3. STUDY OVERVIEW, OBJECTIVES & HYPOTHESES 
3.1. STUDY OVERVIEW 
The purpose of this project was to determine the accuracy and utility of various 
consumer-grade, wrist-worn activity monitors for measuring physical activity metrics in 
adults with and without T1D. Two similar, but separate, studies were conducted for this 
project. Study A was a pre-pilot study that was conducted in 20 healthy adults using two 
common consumer-grade, wrist-worn activity monitors (Fitbit Charge 2 [FC2], Garmin 
vívosmart HR+ [GVHR+]) during 4 types of common physical activity. Study B was a 
follow-up study that was conducted in 15 adults (9 T1D, 6 healthy) using two newer 
consumer-grade, wrist-worn activity monitors (Fitbit Ionic [FI], Garmin vívosmart 3 
[GV3]) during 5 types of common physical activity. 
Study A and B were the first phases of a larger, multicentre, long-term project, 
known as the Type 1 Diabetes and Exercise Initiative (T1DEXI), supported by the 
Helmsley Trust. One of the long-term goals of this research are to find activity monitors 
that are accurate enough at measuring EE and other physical activity parameters to be 
incorporated into an AP system. 
 
3.2. PRIMARY OBJECTIVES 
The primary objective of Study A was to determine if the FC2 and GVHR+ were 
accurate (i.e. 10% error of a laboratory standard) (50,51,53) at measuring EE during 
different types of physical activity in healthy adults. 
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The primary objective of Study B was to determine if the FI and GV3 were 
accurate (i.e. 10% error of a laboratory standard) (50,51,53) at measuring EE during 
different types of physical activity in adults with and without T1D. 
 
3.3. SECONDARY OBJECTIVES 
The secondary objectives of Study A were: 
• to examine the %RE in metabolic equivalents (METs) for the FC2 and 
GVHR+ 
• to examine the %RE in volume of oxygen consumption (VO2) for the FC2 
and GVHR+ 
The secondary objectives of Study B were: 
• to examine glucose changes over the time of exercise 
• to examine the time spent in euglycemia (3.9-10.0 mmol/L) during and for 
12 hours post-exercise 
• to examine the time spent in hypoglycemia (<3.9 mmol/L) during and for 
12 hours post-exercise 
• to examine the time spent in hyperglycemia (>10.0 mmol/L) during and for 
12 hours post-exercise 
 
3.4. HYPOTHESES 
For Study A, it was hypothesized that the FC2 and GVHR+ would display a 
similar level of accuracy to each other, but would not achieve an acceptable level (i.e. 
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10% %RE) of accuracy at measuring EE during different types of physical activity in 
healthy adults (35–37,42,45,47,53). 
For Study B, it was hypothesized that the newer, consumer-grade activity 
monitors, the FI and GV3, would display greater accuracy than the FC2 and GVHR+, 
but would not achieve an acceptable level (i.e. 10% %RE) of accuracy at measuring 
EE during different types of physical activity in adults with and without T1D (35–
37,42,45,47,53). Although this has not previously been assessed, we hypothesized that 
there would no difference in the accuracy of EE measurements between individuals with 
and without T1D. In addition, we hypothesized that there would be a greater decrease in 
BG in individuals with T1D during exercise visit 1 (three moderate- to vigorous-intensity 
activities) compared to visit 2 (one low- and one high-intensity activity) (58–63). 
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4. STUDY A: PRE-PILOT STUDY 
4.1. METHODS 
4.1.1. Participants 
Twenty healthy adults (10 subjects at York University, 10 subjects at Oregon 
Health and Science University) were recruited for this study. All participants provided 
written informed consent before taking part in the study. All participants were screened 
for cardiovascular complications using the Physical Activity Readiness Questionnaire for 
Everyone (PAR-Q+) (64). Physical activity levels were assessed in all participants using 
the International Physical Activity Questionnaire (IPAQ) (65). This study was approved 
by the Human Participants Review Sub-Committee at York University (Toronto, Ontario) 
(Certificate #: e2018-010) and the Institutional Review Board at Oregon Health and 
Science University (Portland, Oregon). 
 
4.1.2. Study Protocol 
Participants attended the research laboratory on two separate occasions, 
separated by a minimum of 24 hours. Anthropometrics were gathered on all participants 
at the beginning of their first laboratory visit. After completing this, participants 
performed a progressive aerobic exercise test to peak oxygen consumption on a 
treadmill (VO2 peak-T) or cycle ergometer (VO2 peak-C) and a resistance exercise 
circuit (described in more detail in section 4.1.2.1. Exercise Visit #1). During the second 
laboratory visit, participants performed a series of common activities of daily living (ADL) 
and high-intensity interval training on a treadmill (HIIT-T) or cycle ergometer (HIIT-C) 
(described in more detail in section 4.1.2.2. Exercise Visit #2). All participants wore a 
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portable metabolic system (Cosmed K4b2/K5), a HR monitor (Polar A300 and Polar H7), 
and two wrist-worn, consumer-grade activity monitors (FC2, GVHR+) during all 
exercises (described in more detail in section 4.1.3. Devices). 
During the first laboratory visit and prior to starting exercise, anthropometrics 
were gathered on all participants. Height was measured using a wall-mounted 
stadiometer to the nearest 0.1 cm. Participants were instructed to remove their shoes 
and stand up straight against the stadiometer with their back and heels touching the 
wall. They were instructed to take a deep breath and exhale, after which point an 
investigator lowered the headpiece to the top of the participant’s head. The participant 
was asked to step away from the wall and their height was recorded. Weight and body 
fat percentage (BF%) were measured using the Tanita BF-350 Total Body Composition 
Analyzer scale (Tanita Corporation, Tokyo, Japan) to the nearest 0.1 kg and 0.1%, 
respectively. Participant’s sex, age, and height were entered into the Tanita scale. Once 
this information had been entered into the scale, participants were instructed to remove 
their shoes and socks, step on the scale, and remain standing on the scale until their 
weight and BF% were displayed on the screen and recorded. Waist circumference (WC) 
and wrist circumference were measured using a soft vinyl tape measure by one of the 
study investigators to the nearest 0.1 cm. WC was measured horizontally around the 
abdomen at the level of the iliac crest (66). Wrist circumference was measured adjacent 
and proximal to the styloid bone of the ulna on the dominant hand. Blood pressure and 
resting HR were measured using the OMRON M7 Intelli IT blood pressure monitor and 
OMRON Intelli Wrap HEM-FL31 blood pressure cuff (OMRON Corporation, Kyoto, 
Japan). Participants were seated in a chair with the blood pressure cuff wrapped around 
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their left arm, which was placed on a table at chest height next to them. Participants 
were instructed to relax, not speak, and keep their legs uncrossed and feet flat on the 
floor during the measurements (67,68). Duplicate blood pressure and resting HR 
measurements were taken 60 seconds apart and then averaged together. 
 
4.1.2.1. Exercise Visit #1 
Participants arrived at the lab in exercise-appropriate clothing (e.g. t-shirt, tank 
top, shorts, leggings, etc.). After initial anthropometrics had been measured and 
recorded, two consumer-grade activity monitors (FC2, GVHR+) were placed on 
opposing wrists (as per manufacturer’s instructions) on the participant in a randomized 
and counterbalanced method. In addition, all participants wore a portable metabolic 
system (Cosmed K4b2/K5) and a HR monitor (Polar H7 and A300) during all exercises. 
All participants were given a 5-minute rest period for baseline assessment and 
recovery, before and after each exercise, respectively. Participants were instructed to 
remain seated during these assessments. Once the Cosmed K4b2/K5 and both activity 
monitors had been placed into the appropriate activity mode (Appendix A), study 
investigators started recording on all devices, which began the 5-minute, pre-exercise 
rest. Five minutes after each exercise ended, the devices were stopped and the 5-
minute, post-exercise rest ended. 
The first exercise participants performed was the VO2 peak-T/VO2 peak-C. 
Participants were assigned to a mode of exercise (i.e. treadmill or cycle ergometer) in a 
randomized and counterbalanced method by investigators. For the VO2 peak-T, each 
participant began with a 4-minute walking warm-up (3.0 mph, 0% grade for 2 min and 
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then 3.0 mph, 5% grade for 2 min) on the Spirit CT850 treadmill (Dyaco International, 
Taipei, Taiwan). After the warm-up, participants self-selected a comfortable running 
speed between 4 to 6 mph, and subsequently, the treadmill incline was increased by 
2% every 2 minutes until the participants reached volitional exhaustion (52). After 
reaching exhaustion, participants completed a 2-minute walking cool down at 2.5 mph 
and 0% incline. For the VO2 peak-C, each participant began with a 2-minute warm-up 
(60 rpm, 0 W) on the Lode Corival cycle ergometer (Lode BV, Groningen, Netherlands). 
After the warm-up, the cadence was maintained at 60 rpm and the power output was 
increased every 2 minutes by 25 W for females and 30 W for males until the participants 
reached volitional exhaustion. After reaching exhaustion, participants completed a 2-
minute cycling cool down at 60 rpm and 0 W. At the end of each 2-minute workload, 
participants’ HR was recorded from Polar and they were asked to assess their level of 
physical exertion using the Borg Rating of Perceived Exertion (RPE) 10-point scale (69). 
The second exercise participants completed was a resistance exercise circuit. 
This consisted of two identical circuits of 6 separate exercises completed for 8 
repetitions each. The pace of the exercises was set at 3-0-1-0, meaning that the 
eccentric component of each exercise was performed for 3 seconds, followed by a 
pause, and then the concentric component of the exercise was performed for 1 second, 
followed by another pause. The 6 exercises performed were dumbbell bicep curls, 
Romanian deadlifts, Bulgarian split squat, dumbbell bench press, dumbbell shoulder 
press, and dumbbell step-ups. Prior to performing each exercise, participants were 
instructed to select a suitable dumbbell weight with which they could maintain proper 
form for 8 repetitions before reaching muscular fatigue. Each set of exercises was 
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separated by 60 seconds of rest (e.g. 8 repetitions of dumbbell bicep curls, 60 seconds 
of rest, 8 repetitions of Romanian deadlifts, 60 seconds of rest, etc.). After all 6 
exercises had been completed once, participants had a 5-minute rest and then repeated 
the entire circuit of exercises again in the same order. After each exercise, participants’ 
HR was recorded from Polar. After the first and last exercise of each circuit (i.e. 
dumbbell bicep curls and dumbbell step-ups), participants were asked to assess their 
level of physical exertion using the RPE scale. 
After the VO2 peak-T/VO2 peak-C and resistance exercises had been completed, 
participants left the laboratory. 
 
4.1.2.2. Exercise Visit #2 
After 24 hours, participants returned to the research laboratory in exercise 
clothing to complete ADL and HIIT-T/HIIT-C. The Cosmed K4b2/K5 and both activity 
monitors were placed on participants in the same locations and on the same wrists as 
the previous laboratory visit. 
All participants were again given a 5-minute rest period for baseline assessment 
and recovery, before and after each exercise, respectively. Participants were instructed 
to remain seated during these assessments. Once the Cosmed K4b2/K5 and both 
activity monitors had been placed into the appropriate activity mode (Appendix A), study 
investigators started recording on all devices, which began the 5-minute, pre-exercise 
rest. Five minutes after each exercise ended, the devices were stopped and the 5-
minute, post-exercise rest ended. 
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Participants performed the ADL first. Participants performed six ADL to simulate 
common, daily chores: sitting on a chair, washing dishes, sweeping the floor, organizing 
a room and moving light furniture, scrubbing the walls and floor, and self-paced 
ascending and descending of a flight of stairs. Each activity was performed for 3 
minutes in duration, for a total time of 18 minutes. At the end of each activity, 
participants’ HR was recorded from Polar and they were asked to assess their level of 
physical exertion using the RPE scale. 
The second exercise participants performed was the HIIT-T/HIIT-C. Participants 
performed HIIT in the same mode of exercise (i.e. treadmill or cycle ergometer) as was 
used for the VO2 peak test during the first laboratory visit. For HIIT-T, participants 
alternated between 6 low-intensity (30% of HRR) and 5 high-intensity (80% of HRR) 
intervals on the Spirit CT850 treadmill (70). Prior to the start of exercise, HRR was 
calculated for 30% and 80% intensity for each participant from HR measurements taken 
during the VO2 peak test using the Karvonen formula (71): 
HRR = [(HRmax – HRrest) x % intensity] + HRrest 
To begin, participants walked at a speed and incline corresponding to 30% of 
their HRR, as calculated by the Karvonen formula, for 2 minutes and then ran at a 
speed and incline corresponding to 80% of their HRR for 2 minutes. This continued until 
all 6 low-intensity and 5 high-intensity intervals had been completed. After completing 
the intervals, participants performed a 2-minute walking cool down at a self-selected 
speed and incline. For the HIIT-C, participants alternated between 6 low-intensity (30% 
of peak power output) and 5 high-intensity (80% of peak power output) intervals on the 
Lode Corival cycle ergometer. Prior to the start of exercise, power output was calculated 
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for 30% and 80% of peak power for each participant based on the peak power achieved 
during the VO2 peak test. Peak power was multiplied by 0.3 and 0.8 to determine the 
power output for low- and high-intensity intervals, respectively. Participants cycled at a 
cadence of 60 rpm and 30% of peak power for 2 minutes and then cycled at a cadence 
of 60 rpm and 80% of peak power for 2 minutes. This continued until all 6 low-intensity 
and 5 high-intensity intervals had been completed. After completing the intervals, 
participants performed a 2-minute cycling cool down at a self-selected cadence and 
power output. At the end of each 2-minute workload, participants’ HR was recorded 
from Polar and they were asked to assess their level of physical exertion using the RPE 
scale. 
 After the ADL and HIIT-T/HIIT-C had been completed, participants left the 
laboratory. 
 
4.1.3. Devices 
During all exercises, participants wore three research-grade devices (Cosmed 
K4b2/K5, Polar A300, Polar H7) and two wrist-worn, consumer-grade activity monitors 
(FC2, GVHR+). 
 
4.1.3.1. Research-Grade Devices 
The Cosmed K4b2 and Cosmed K5 (Cosmed, Rome, Italy) are validated, 
wearable, and portable indirect calorimeters that measure various metabolic 
parameters, such as volume of oxygen consumption (VO2), volume of carbon dioxide 
production (VCO2), and ventilation (72–75). The Cosmed K4b2/K5 units were calibrated 
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before each testing session according to the manufacturer’s instructions. The Cosmed 
K4b2/K5 calculated EE from the direct measurement of VO2 and VCO2. EE data was 
downloaded from the Cosmed K4b2/K5-associated software platform, OMNIA (version 
1.6.5). 
The Polar H7 (Polar Electro, Kempele, Finland) chest strap HR monitor 
measured HR at the chest through electrodes on a wearable chest strap and 
transmitted it to the Polar A300 (Polar Electro, Kempele, Finland) wrist watch via 
Bluetooth (76). The Polar A300 and H7 were used to monitor participants’ HR during 
exercise. HR measurements from these devices were used to calculate HRR for the 
low- and high-intensity intervals in HIIT-T. 
 
4.1.3.2. Consumer-Grade Devices 
Although there are many consumer-grade activity monitors that are currently 
available, the FC2 and GVHR+ were chosen for this study based on budgetary 
considerations and their ability to integrate with an AP control system running on an 
Android platform. 
The Fitbit Charge 2 (FC2) (2017 version, Fitbit, Inc., California, USA) is a multi-
sensor activity monitor that has an accelerometer, altimeter, and built-in PPG sensor 
that uses the “PurePulse” wrist HR technology to measure HR at the wrist (77). The 
firmware version of the FC2 used in the study was 22.54.6. For the study, the FC2 
recorded each exercise in the mode most closely-related to the exercise being 
performed (Appendix A). After each exercise session was recorded, data was uploaded 
from the FC2 to the Fitbit app (version 2.35) via Bluetooth. A new Fitbit user account 
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was created for each participant prior to the start of the study. These accounts were 
used to access participants’ EE data after the study was completed. Fitbit only provided 
a total EE (kcal) value for each exercise session recorded. Fitabase (Small Steps Labs, 
California, USA) is a third-party research platform designed to collect data from Fitbit 
using the developer application programming interface (API). Fitabase provided access 
to data at a higher sample rate, including EE measured per minute, and access to 
METs estimates. 
The Garmin vívosmart HR+ (GVHR+) (2016 version, Garmin International, Inc., 
Kansas, USA) is a multi-sensor activity monitor that has an accelerometer, altimeter, 
GPS, and built-in PPG sensor that uses the “Elevate” wrist HR technology to measure 
HR at the wrist (78). The firmware version of the GVHR+ used in the study was 3.20. 
For the study, the GVHR+ recorded each exercise in the mode most closely-related to 
the exercise being performed (Appendix A). After each exercise session was recorded, 
data was uploaded from the GVHR+ to the Garmin Connect app (version 3.17) via 
Bluetooth. A new Garmin user account was created for each participant prior to the start 
of the study. These accounts were used to access participants’ EE data after the study 
was completed. Garmin provided a total EE (kcal) value for each exercise session 
recorded. 
 
4.1.4. Statistical Analysis 
The sample size of this study was calculated using the primary outcome measure 
of accuracy (i.e. %RE) in EE. The minimal difference in %RE to be detected was set as 
5%, with a power of 0.8 and an alpha level of 0.05. Using G*Power (Heinrich Heine 
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University Düsseldorf, Düsseldorf, Germany, version 3.1.9.3), we calculated a sample 
size of 26 total subjects. 
Data from the consumer-grade activity monitors were compared to the Cosmed 
K4b2/K5, which was used as the reference standard for EE, METs, and VO2 
measurements. Using the METs measurements from the FC2, VO2 estimates were 
calculated using the following equation (79): 
VO2 (mL/min/Kg) = METs x 3.5 
Mean relative percentage error (%RE) and mean absolute percentage error (MAPE) 
were calculated to determine the amount of error between the consumer-grade devices 
and the reference standard. Mean relative percentage error and MAPE were calculated 
using the following formulas (41): 
%RE =  [(consumer device – research device) / research device] x 100 
 
MAPE =  | [(consumer device – research device) / research device] | x 100 
 
No standardized thresholds exist for high or low %RE or MAPE, but a 10% mean error 
limit for the various activity was adopted for this study, similar to other studies 
(50,51,53). Error in EE was calculated across an entire exercise session as higher 
resolution data could not be obtained from all devices. 
Mixed-effects analysis of variance (ANOVA) with the Geisser-Greenhouse 
correction and Tukey’s honestly significant difference (HSD) post-hoc test was 
performed to assess the difference in total EE between the Cosmed K4b2/K5, FC2, and 
GVHR+ for each exercise. Matched paired t-tests were performed to assess the 
n 
n 
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difference in %RE and MAPE of EE between the FC2 and GVHR+ for each exercise. 
One-way ANOVA with Tukey’s HSD post-hoc test was performed to assess the 
difference in %RE of EE, METs, and VO2 and MAPE of EE between exercises within 
each device. Unpaired t-tests with Welch’s correction were performed to assess the 
difference in %RE of EE between dominant and non-dominant hand wear for each 
device. Linear regression, the Pearson (r) correlation coefficient and Bland-Altman 
analysis were used to assess the agreement and bias between the consumer-grade 
devices and the reference standard. Linear regression and the Pearson (r) correlation 
coefficient were also used to examine the relationship between %RE and different 
anthropometric measures. All statistical analyses were conducted in GraphPad Prism 8 
(GraphPad Software, California, USA, version 8.0.0). Statistical significance was set at 
P<0.05. All data are presented as mean ± SD. 
 
4.2. RESULTS 
4.2.1. Participants 
All 20 participants completed the study. Table 10 describes participant 
characteristics. 
 
4.2.2. Data Loss 
There was no data loss from the FC2, but there was some data loss that 
occurred for the GVHR+. For two participants, study investigators failed to stop and 
restart recording on the GVHR+ between VO2 peak and resistance exercise, so total EE 
for each individual activity was not known. One participant accidentally hit the stop 
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button on the GVHR+ during HIIT, so the second half of the exercise session was not 
recorded and the total EE for that activity was unknown. For unknown reasons, no EE 
data was recorded on the GVHR+ for any activity for two participants. 
 
4.2.3. Energy Expenditure Accuracy 
Both the FC2 and GVHR+ performed reasonably well at measuring EE overall, 
but considerable error was displayed during some activities, specifically during cycling 
activities for the FC2 and resistance exercise for the GVHR+. Table 11 presents pooled 
EE data from each exercise for the FC2 and the GVHR+. 
The FC2 displayed a significant underestimation in total EE measurements 
during VO2 peak (Cosmed: 231.3 ± 71.9 kcal, FC2: 162.9 ± 69.3 kcal, P<0.01) and HIIT 
(Cosmed: 239.7 ± 58.6 kcal, FC2: 169.7 ± 71.2, P<0.01) compared to the Cosmed 
K4b2/K5, while the GVHR+ displayed a significant overestimation in total EE during VO2 
peak (FC2: 162.9 ± 69.3 kcal, GVHR+: 210.8 ± 49.7 kcal, P<0.05) and resistance 
exercise (FC2: 130.2 ± 46.2 kcal, GVHR+: 179.8 ± 56.8 kcal, P<0.0001) compared to 
the FC2 (Figure 1). 
The correlational relationships in EE measurements between Cosmed and the 
consumer-grade devices ranged from -0.26 to 0.88 for the FC2 and 0.11 to 0.60 for the 
GVHR+ (Table 11). The FC2 had the strongest correlation with Cosmed during HIIT-T 
(r=0.88) and the weakest correlation during HIIT-C (r=-0.26), while the GVHR+ also had 
the strongest correlation with Cosmed during HIIT-T (r=0.60) and the weakest 
correlation during VO2 peak-T (r=0.11). 
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Correlation plots for total EE on Cosmed and total EE on the FC2 and GVHR+ 
demonstrated that both devices generally displayed an underestimation in EE compared 
to Cosmed, as seen by the majority of EE values appearing below the line of identity on 
the plots (Figure 2). The greatest underestimation in EE measurements occurred during 
VO2 peak and HIIT on the FC2, with almost all of the EE values below the line of identity 
(Figure 2A and 2G), and the greatest overestimation occurred during resistance 
exercise on the GVHR+, with the majority of the EE values appearing above the line of 
identity (Figure 2D). 
MAPE ± SD for the FC2 and GVHR+ was 27.0 ± 21.8% and 25.1 ± 17.3%, 
respectively (Figure 3). The lowest MAPE in EE was observed during all treadmill 
exercises (16.9 ± 10.9%) for the FC2 and ADL (17.0 ± 13.7%) for the GVHR+. The 
highest MAPE was observed during all cycling exercises (42.7 ± 26.8%) for the FC2 
and resistance exercise (35.7 ± 19.7%) for the GVHR+. The GVHR+ was significantly 
more accurate than the FC2 at measuring EE during VO2 peak (FC2: 31.5 ± 21.5%, 
GVHR+: 22.9 ± 16.8%, P<0.05) and during all cycling exercises (FC2: 42.7 ± 26.8%, 
GVHR+: 22.8 ± 16.6%, P<0.05). 
Mean relative percentage error in EE measurements from the FC2 and GVHR+ 
differed significantly, with the GVHR+ displaying less negative bias (i.e. 
underestimation) overall (FC2: -19.3 ± 28.9%, GVHR+: -1.6 ± 30.6%, P<0.001) (Figure 
4). The lowest mean %RE in EE measurements was observed during ADL (-8.8 ± 
29.2%) for the FC2 and VO2 peak-C (-4.5 ± 25.3%) and HIIT-T (-4.7 ± 29.3%) for the 
GVHR+. The highest mean %RE was observed during VO2 peak-C (-39.1 ± 30.6%) and 
HIIT-C (-41.9 ± 31.3%) for the FC2 and resistance (21.0 ± 35.7%) for the GVHR+. 
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Bland-Altman plots demonstrated that both the FC2 and GVHR+ displayed a 
negative bias in EE measurements when compared to Cosmed, with the FC2 displaying 
a greater mean difference from Cosmed than the GVHR+ (FC2: -43.1 ± 63.4 kcal, 
GVHR+: -12.2 ± 61.5 kcal) (Figure 5). However, the plots also revealed similar 95% LoA 
for both the FC2 (difference: 248.4 kcal) and the GVHR+ (difference: 241.0 kcal). In 
addition, the plots indicated that the greatest difference in EE measurements occurred 
during activities performed on the cycle ergometer, as demonstrated by the majority of 
EE values lying outside the LoA when cycling activities were performed. 
Both the FC2 and GVHR+ demonstrated negative bias when activities were 
performed on the treadmill (FC2: -15.1 ± 13.5%, GVHR+: -7.4 ± 30.1%) (Figure 6). For 
activities performed on the cycle ergometer, both devices displayed a negative bias, but 
there was significantly greater mean error on the FC2 compared to the GVHR+ (FC2: -
40.5 ± 30.2%, GVHR+: -7.9 ± 27.6%, P<0.0001). 
Correlation plots of EE measurements in kcal/min from Cosmed and the FC2 
demonstrate that the FC2 primarily underestimated EE during VO2 peak, HIIT, all 
pooled treadmill exercises, and all pooled cycle ergometer exercises compared to 
Cosmed, as seen by the majority of EE values appearing below the line of identity 
(Figure 7). The FC2 displayed the greatest accuracy in EE measurements during ADL 
(Figure 7C), while the greatest inaccuracy and underestimation in EE measurements 
occurred during cycling exercises (Figure 6F). The EE values clustered in a horizontal 
line above the x-axis in Figure 6F demonstrates that although Cosmed was measuring 
EE from 1-20 kcal/min, the FC2 was unable to accurately detect these values and 
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inaccurately measured EE as being between only 1-2 kcal/min during 49.5% of cycling 
activities. 
Individual subject data from cycling exercise demonstrates that the 
underestimation in EE measurements occurred for at least 3 minutes or more during all 
VO2 peak-C and HIIT-C sessions by the FC2 and low, inaccurate EE measurements 
were reported during partial and for full durations of activities (Appendix B). In some 
instances, the FC2 reported low, inaccurate EE values (<2 kcal/min) for the first 3-6 
minutes of activity, but then reported higher values (>2 kcal/min) for the rest of the 
activity (Appendix BA, BC, BF, and BJ). In other cases, the FC2 reported low, 
inaccurate EE values for the majority or full duration of exercise (Appendix BE, BG, BH, 
and BI). 
There was no significant difference in the %RE of EE measurements between 
dominant hand and non-dominant hand wear for either the FC2 or the GVHR+ 
(Appendix C). 
Moderate or strong relationships were not displayed between %RE for the 
devices and most of the anthropometrics measured (Appendix D). However, a 
moderate, positive relationship was displayed between %RE in EE for the GVHR+ and 
BF% (r=0.40, P<0.05) (Appendix DJ). 
 
4.2.4. METs and VO2 Accuracy 
METs values for the FC2 were retrieved from Fitabase and used to calculate 
VO2. METs and VO2 measurements from the FC2 displayed a negative bias (METS: -
14.6 ± 30.7%, VO2: -14.5 ± 30.0%) (Appendix E), similar to EE measurements. The 
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Garmin Connect application does not provide METs data, so METs and VO2 
measurements could not be analyzed for the GVHR+. 
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5. STUDY B: PILOT STUDY 
5.1. METHODS 
5.1.1. Participants 
Fifteen adults (9 T1D, 6 healthy controls) were recruited for this study. All 
participants provided written informed consent before taking part in the study. All 
participants were screened for cardiovascular complications using the Physical Activity 
Readiness Questionnaire for Everyone (PAR-Q+) (64). Physical activity levels were 
assessed in all participants using the International Physical Activity Questionnaire 
(IPAQ) (65). This study was approved by the Human Participants Review Sub-
Committee at York University (Toronto, Ontario) (Certificate #: e2018-010). 
 
5.1.2. Study Protocol 
Participants attended the research laboratory on two separate occasions, 
separated by a minimum of 24 hours. Anthropometrics were gathered on all participants 
at the beginning of their first laboratory visit. After completing this, participants 
performed a progressive aerobic exercise test to peak oxygen consumption on a 
treadmill (VO2 peak-T), a resistance exercise circuit, and high-intensity interval training 
on a cycle ergometer (HIIT-C) (described in more detail in section 5.1.2.1. Exercise Visit 
#1). During the second laboratory visit, participants performed a series of common 
activities of daily living (ADL) and high-intensity interval training on a treadmill (HIIT-T) 
(described in more detail in section 5.1.2.2. Exercise Visit #2). All participants wore a 
portable metabolic system (Cosmed K5), a HR monitor (Polar H10), and two wrist-worn, 
  
55 
consumer-grade activity monitors (FI, GV3) during all exercises (described in more 
detail in section 5.1.3. Devices). 
During the first laboratory visit and prior to starting exercise, anthropometrics 
were gathered on all participants. Height was measured using a wall-mounted 
stadiometer to the nearest 0.1 cm. Participants were instructed to remove their shoes 
and stand up straight against the stadiometer with their back and heels touching the 
wall. They were instructed to take a deep breath and exhale, after which point an 
investigator lowered the headpiece to the top of the participant’s head. The participant 
was asked to step away from the wall and their height was recorded. Weight and BF% 
were measured using the Tanita BF-350 Total Body Composition Analyzer scale (Tanita 
Corporation, Tokyo, Japan) to the nearest 0.1 kg and 0.1%, respectively. Participant’s 
sex, age, and height were entered into the Tanita scale. Once this information had been 
entered into the scale, participants were instructed to remove their shoes and socks, 
step on the scale, and remain standing on the scale until their weight and BF% were 
displayed on the screen and recorded. WC and wrist circumference were measured 
using a soft vinyl tape measure by one of the study investigators to the nearest 0.1 cm. 
WC was measured horizontally around the abdomen at the level of the iliac crest (66). 
Wrist circumference was measured adjacent and proximal to the styloid bone of the 
ulna on the dominant hand. Blood pressure and resting HR were measured using the 
OMRON M7 Intelli IT blood pressure monitor and OMRON Intelli Wrap HEM-FL31 blood 
pressure cuff (OMRON Corporation, Kyoto, Japan). Participants were seated in a chair 
with the blood pressure cuff wrapped around their left arm, which was placed on a table 
at chest height next to them. Participants were instructed to relax, not speak, and keep 
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their legs uncrossed and feet flat on the floor during the measurements (67,68). 
Duplicate blood pressure and resting HR measurements were taken 60 seconds apart 
and then averaged together. Skin tone measurements were taken at the wrist 
independently by two investigators using the Von Luschan Chromatic scale (1-36 tile 
scale) (80). Measurements were always taken away from windows and under florescent 
lights (80). The average of the two measurements were converted to the Fitzpatrick skin 
tone scale (1-6 tile scale) (46,81,82). 
 
5.1.2.1. Exercise Visit #1 
Participants arrived at the lab in exercise-appropriate clothing (e.g. t-shirt, tank 
top, shorts, leggings, etc.). After initial anthropometrics had been measured and 
recorded, two consumer-grade activity monitors (FI, GV3) were placed on opposing 
wrists (as per manufacturer’s instructions) on the participant in a randomized and 
counterbalanced method. In addition, all participants wore a portable metabolic system 
(Cosmed K5) and a HR monitor (Polar H10) during all exercises. 
All participants were given a 5-minute rest period for baseline assessment and 
recovery, before and after each exercise, respectively. Participants were instructed to 
remain seated during these assessments. Once the Cosmed K5 and both activity 
monitors had been placed into the appropriate activity mode (Appendix F), study 
investigators started recording on all devices, which began the 5-minute, pre-exercise 
rest. Five minutes after each exercise ended, the devices were stopped and the 5-
minute, post-exercise rest ended. 
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The first exercise participants performed was the VO2 peak-T. Each participant 
began with a 4-minute walking warm-up (3.0 mph, 0% grade for 2 min and then 3.0 
mph, 5% grade for 2 min) on the Spirit CT850 treadmill (Dyaco International, Taipei, 
Taiwan). After the warm-up, participants self-selected a comfortable running speed 
between 4 to 6 mph, and subsequently, the treadmill incline was increased by 2% every 
2 minutes until the participants reached volitional exhaustion (52). After reaching 
exhaustion, participants completed a 2-minute walking cool down at 2.5 mph and 0% 
incline. At the end of each 2-minute workload, participants’ HR was recorded from Polar 
and they were asked to assess their level of physical exertion using the RPE scale. 
The second exercise participants completed was a resistance exercise circuit. 
This consisted of two identical circuits of 6 separate exercises completed for 8 
repetitions each. The pace of the exercises was set at 3-0-1-0, meaning that the 
eccentric component of each exercise was performed for 3 seconds, followed by a 
pause, and then the concentric component of the exercise was performed for 1 second, 
followed by another pause. The 6 exercises performed were dumbbell bicep curls, 
Romanian deadlifts, Bulgarian split squat, push-ups, dumbbell shoulder press, and 
dumbbell step-ups. Prior to performing each exercise, participants were instructed to 
select a suitable dumbbell weight with which they could maintain proper form for 8 
repetitions before reaching muscular fatigue. Dumbbells were used for all exercises, 
except for push-ups, which were performed using body weight. Each set of exercises 
was separated by 60 seconds of rest (e.g. 8 repetitions of dumbbell bicep curls, 60 
seconds of rest, 8 repetitions of Romanian deadlifts, 60 seconds of rest, etc.). After all 6 
exercises had been completed once, participants had a 5-minute rest and then repeated 
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the entire circuit of exercises again in the same order. After each exercise, participants’ 
HR was recorded from Polar. After the first and last exercise of each circuit (i.e. 
dumbbell bicep curls and dumbbell step-ups), participants were asked to assess their 
level of physical exertion using the RPE scale. 
Following a 1-hour rest, participants performed HIIT-C. Participants alternated 
between 6 low-intensity (RPE of 2) and 5 high-intensity (RPE of 8) intervals on the Lode 
Corival cycle ergometer (Lode BV, Groningen, Netherlands) (70). Participants were 
instructed to cycle at a power output that they considered to be equivalent to an RPE of 
~2 and ~8 for the low- and high-intensity intervals, respectively. Once the power outputs 
had been determined for each interval during the first low- and first high-intensity 
intervals, they were kept consistent for the rest of the exercise. Participants cycled at a 
cadence of 60 rpm and a power output equivalent to an RPE of 2 for 2 minutes and then 
cycled at a cadence of 60 rpm and a power output equivalent to an RPE of 8 for 2 
minutes. This continued until all 6 low-intensity and 5 high-intensity intervals had been 
completed. After completing the intervals, participants performed a 2-minute cycling 
cool down at a self-selected cadence and power output. At the end of each 2-minute 
workload, participants’ HR was recorded from Polar and they were asked to assess 
their level of physical exertion using the RPE scale. 
After the VO2 peak-T, resistance exercises, and HIIT-C had been completed, 
participants left the laboratory. 
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5.1.2.2. Exercise Visit #2 
After 24 hours, participants returned to the research laboratory in exercise 
clothing to complete ADL and HIIT-T. The Cosmed K5 and both activity monitors were 
placed on participants in the same locations and on the same wrists as the previous 
laboratory visit. 
All participants were again given a 5-minute rest period for baseline assessment 
and recovery, before and after each exercise, respectively. Participants were instructed 
to remain seated during these assessments. Once the Cosmed K5 and both activity 
monitors had been placed into the appropriate activity mode (Appendix F), study 
investigators started recording on all devices, which began the 5-minute, pre-exercise 
rest. Five minutes after each exercise ended, the devices were stopped and the 5-
minute, post-exercise rest ended. 
Participants performed the ADL first. As in Study A, participants performed six 
ADL to simulate common, daily chores: sitting on a chair, washing dishes, sweeping the 
floor, organizing a room and moving light furniture, scrubbing the walls and floor, and 
self-paced ascending and descending of a flight of stairs. Each activity was performed 
for 3 minutes in duration, for a total time of 18 minutes. At the end of each activity, 
participants’ HR was recorded from Polar and they were asked to assess their level of 
physical exertion using the RPE scale. 
The second exercise participants performed was the HIIT-T. Participants 
alternated between 6 low-intensity (30% of HRR) and 5 high-intensity (80% of HRR) 
intervals on the Spirit CT850 treadmill (70). Prior to the start of exercise, HRR was 
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calculated for 30% and 80% intensity for each participant from HR measurements taken 
during the VO2 peak test using the Karvonen formula (71): 
HRR = [(HRmax – HRrest) x % intensity] + HRrest 
To begin, participants walked at a speed and incline corresponding to 30% of 
their HRR, as calculated by the Karvonen formula, for 2 minutes and then ran at a 
speed and incline corresponding to 80% of their HRR for 2 minutes. This continued until 
all 6 low-intensity and 5 high-intensity intervals had been completed. After completing 
the intervals, participants performed a 2-minute walking cool down at a self-selected 
speed and incline. At the end of each 2-minute workload, participants’ HR was recorded 
from Polar and they were asked to assess their level of physical exertion using the RPE 
scale. 
 After the ADL and HIIT-T had been completed, participants left the laboratory. 
 
5.1.3. Devices 
During all exercises, participants wore two research-grade devices (Cosmed K5, 
Polar H10) and two wrist-worn, consumer-grade activity monitors (FI, GV3). 
 
5.1.3.1. Research-Grade Devices 
The Cosmed K5 (Cosmed, Rome, Italy) is a validated, wearable, and portable 
indirect calorimeter that measures various metabolic parameters, such as VO2, VCO2, 
and ventilation (74,75). The Cosmed K5 unit was calibrated before each testing session 
according to the manufacturer’s instructions. The Cosmed K5 calculated EE from the 
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direct measurement of VO2 and VCO2. EE data was downloaded from the Cosmed K5-
associated software platform, OMNIA (version 1.6.5). 
The Polar H10 (Polar Electro, Kempele, Finland) chest strap HR monitor 
measured HR at the chest through electrodes on a wearable chest strap and 
transmitted it to the Polar Beat app (version 2.6.3) via Bluetooth (76). The Polar H10 
and the Polar Beat app were used to monitor participants’ HR during exercise. HR 
measurements from Polar were used to calculate HRR for the low- and high-intensity 
intervals in HIIT-T. 
 
5.1.3.2. Consumer-Grade Devices 
Based on the greater accuracy displayed by the GVHR+ in Study A, the GV3 was 
selected to be used in this study, which is the newest version of the GVHR+. Due to the 
poor results displayed by the FC2 in Study A, the FC2 was not chosen to be used in this 
study, but the FI, a newer and higher end activity monitor developed by Fitbit, was 
chosen to be used in this study instead. Both devices have the ability to integrate with 
an AP control system running on an Android platform. 
The Fitbit Ionic (FI) (2018 version, Fitbit, Inc., California, USA) is a multi-sensor 
activity monitor that has an accelerometer, altimeter, gyroscope, GPS, and built-in PPG 
sensor that uses the “PurePulse” wrist HR technology to measure HR at the wrist (83). 
The firmware version of the FI used in the study was 32.10.20. For the study, the FI 
recorded each exercise in the mode most closely-related to the exercise being 
performed (Appendix F). After each exercise session was recorded, data was uploaded 
from the FI to the Fitbit app (version 2.81.1) via Bluetooth. A new Fitbit user account 
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was created for each participant prior to the start of the study. These accounts were 
used to access participants’ EE data after the study was completed. Fitbit provided a 
total EE (kcal) value for each exercise session recorded. Due to limited funding, a 
Fitabase subscription could not be acquired for this study, so data at a higher sample 
rate (i.e. EE in kcal/min) and METs data could not be analyzed in this study. 
The Garmin vívosmart 3 (GV3) (2018 version, Garmin International, Inc., Kansas, 
USA) is a multi-sensor activity monitor that has an accelerometer, altimeter, and built-in 
PPG sensor that uses the “Elevate” wrist HR technology to measure HR at the wrist 
(84). The firmware version of the GV3 used in the study was 5.00. For the study, the 
GV3 recorded each exercise in the mode most closely-related to the exercise being 
performed (Appendix F). After each exercise session was recorded, data was uploaded 
from the GV3 to the Garmin Connect app (version 4.15.1.2) via Bluetooth. A new 
Garmin user account was created for each participant prior to the start of the study. 
These accounts were used to access participants’ EE data after the study was 
completed. Garmin provided a total EE (kcal) value for each exercise session recorded. 
 
5.1.4. Glucose 
Glucose was monitored before, during, and after exercise using SMBG and 
CGM. SMBG was performed before and after each exercise, while CGM was worn 
continuously. Sixty seconds before the start of exercise (during the 5-minute, pre-
exercise rest) and immediately after completing exercise (during the 5-minute, post-
exercise rest), duplicate SMBG measurements were taken. Participants were instructed 
to clean their finger with a BD alcohol swab (Becton, Dickinson and Company, New 
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Jersey, USA) and then dry their finger with a tissue. They were asked to squeeze and 
wipe away the first drop of blood to avoid testing blood that may be contaminated with 
substances from the surface of the skin, such as alcohol, food, or sweat, that may 
impact the accuracy of the BG measurement (85,86). Participants were asked to 
produce a second and third drop of blood, which were then tested using the CONTOUR 
NEXT LINK glucometer and CONTOUR NEXT blood glucose test strips (Ascensia 
Diabetes Care Holdings AG, Basel, Switzerland) (87). The two BG measurements were 
averaged together. If the measurements were >1.0 mmol/L apart, a third measurement 
was taken and the two closest BG measurements were averaged together. 
BG was checked prior to the start of exercise to ensure individuals with T1D were 
in a safe glycemic range (i.e. 5-15 mmol/L) to exercise (88). If BG from SMBG was <5 
mmol/L prior to exercise start, participants were asked to ingest 3-4 Dex4 glucose 
tablets (12-16g of carbohydrates) (AMG Medical Inc., Quebec, Canada) and wait 15 
minutes to allow BG to rise to a safe level. After 15 minutes, BG was checked using 
SMBG. If BG was 5 mmol/L, exercise was initiated. If BG was still below <5 mmol/L, 
participants were asked in ingest another 1-2 Dex4 tabs (4-8 g of carbohydrates) and 
wait another 15 minutes. If BG was >15 mmol/L, participants were tested for ketones 
using the FreeStyle Precision Neo meter and FreeStyle Precision Blood β-ketone test 
strips (Abbott Laboratories, Illinois, USA). If ketones were <1.5 mmol/L, exercise was 
initiated. If ketones were 1.5 mmol/L, exercise was not started and participants were 
asked to initiate their usual diabetes care (88). 
At least 24 hours prior to their first laboratory visit, participants were set up with 
a Dexcom G5 CGM system (Dexcom, Inc., California, USA). The Dexcom G5 CGM 
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measures interstitial glucose every 5 minutes through a sensor inserted into 
subcutaneous tissue and transmits it to the Dexcom G5 Mobile app (version 1.7.5) on 
the user’s smartphone via Bluetooth (89–91). Participants’ glucose data from exercise 
and for 12 hours post-exercise was downloaded using Dexcom CLARITY (version 
3.22.1), a web-based software for healthcare professionals and researchers to access 
and analyze CGM data. 
Participants’ BG was closely monitored throughout exercise using CGM. If CGM 
indicated glucose was exceeding the safe glycemic range for exercise, BG was tested 
using SMBG. If participants’ BG was <3.9 mmol/L, exercise was stopped and 
participants were asked to ingest 3-4 Dex4 tabs and wait 15 minutes. After 15 minutes, 
BG was checked using SMBG. If BG was 3.9 mmol/L, exercise was continued. If BG 
was still below <3.9 mmol/L, participants were asked in ingest another 1-2 Dex4 tabs 
and wait another 15 minutes. If BG was >15 mmol/L, participants were tested for 
ketones. If ketones were <1.5 mmol/L, exercise was continued. If ketones were 1.5 
mmol/L, exercise was terminated and participants were asked to initiate their usual 
diabetes care (88). 
 
5.1.5. Statistical Analysis 
The sample size of this study was calculated using the primary outcome measure 
of accuracy (i.e. %RE) in EE. The minimal difference in %RE to be detected was set as 
5%, with a power of 0.8 and an alpha level of 0.05. Using G*Power (Heinrich Heine 
University Düsseldorf, Düsseldorf, Germany, version 3.1.9.3), we calculated a sample 
size of 198 total subjects. 
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Data from the consumer-grade activity monitors were compared to the Cosmed 
K5, which was used as the reference standard for EE measurements. Mean relative 
percentage error (%RE) and MAPE were calculated to determine the amount of error 
between the consumer-grade devices and the reference standard. Mean relative 
percentage error and MAPE were calculated using the following formulas (41): 
%RE =  [(consumer device – research device) / research device] x 100 
 
MAPE =  | [(consumer device – research device) / research device] | x 100 
 
No standardized thresholds exist for high or low %RE or MAPE, but a 10% mean error 
limit for the various activity was adopted for this study, similar to other studies 
(50,51,53). Error in EE was calculated across an entire exercise session as higher 
resolution data could not be obtained from the devices. 
 CGM data was analyzed for percentage of time in hypoglycemia, euglycemia, 
and hyperglycemia during exercise and for 12 hours post-exercise. Based on the 
recommendations by Danne et al. (3), the euglycemic target range was set as 3.9-10.0 
mmol/L, while <3.9 mmol/L was considered hypoglycemia and >10.0 mmol/L was 
considered hyperglycemia. 
Mixed-effects analysis of variance (ANOVA) with the Geisser-Greenhouse 
correction and Tukey’s HSD post-hoc test was performed to assess the difference in 
total EE between the Cosmed K5, FI, and GV3 for each exercise. Matched paired t-
tests were performed to assess the difference in %RE and MAPE of EE between the FI 
and GV3 for each exercise. One-way repeated measures ANOVA with Tukey’s HSD 
n 
n 
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post-hoc test was performed to assess the difference in %RE and MAPE of EE between 
exercises within each device. Unpaired t-tests with Welch’s correction were performed 
to assess the difference in %RE of EE between T1D and control subjects and between 
dominant and non-dominant hand wear for each device. Linear regression, the Pearson 
(r) correlation coefficient and Bland-Altman analysis were used to assess the agreement 
and bias in total EE between the consumer-grade devices and the reference standard. 
Linear regression and the Pearson (r) correlation coefficient were also used to examine 
the relationship between %RE and different anthropometric measures. For SMBG 
measurements, matched paired t-tests were performed to assess the difference in BG 
from pre- to post-exercise in each visit. Unpaired t-tests with Welch’s correction were 
performed to assess the difference in BG between T1D and control subjects at the start 
and end of each visit. Unpaired t-tests with Welch’s correction were also performed to 
assess the change in BG during each exercise between T1D and control subjects. One-
way repeated measures ANOVA with Tukey’s HSD post-hoc test was performed to 
assess the change in BG between exercises within each group of subjects. All statistical 
analyses were conducted in GraphPad Prism 8 (GraphPad Software, California, USA, 
version 8.0.0). Statistical significance was set at P<0.05. All data are presented as 
mean ± SD. 
 
5.2. RESULTS 
5.2.1. Participants 
Fourteen participants (8 T1D, 6 healthy) completed both visit 1 and 2. An 
additional participant with T1D only completed visit 1. All data collected, including the 
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participant who only completed visit 1, has been included in the Results. Table 12 
describes participant characteristics. 
 
5.2.2. Data Loss 
There was some data loss that occurred for both the FI and GV3. The FI would 
not pair with one participant’s Fitbit account prior to the start of VO2 peak, so no EE data 
was recorded for this activity session. One participant did not complete HIIT-C, as they 
were the first subject to complete the study before the protocol was finalized. One other 
participant accidentally hit the stop button on the FI during HIIT-T, so the second half of 
the exercise session was not recorded and the total EE for that activity was unknown. 
Despite recording the exercise sessions, the GV3 did not report any total EE value 
during resistance exercise and HIIT-C for one participant and during VO2 peak, 
resistance, and HIIT-C for another participant for unknown reasons. 
During the data collection process, the Cosmed K5 began malfunctioning and 
was sent out for repair. The Cosmed Fitmate Pro (Cosmed, Rome, Italy) was used with 
two participants in place of the Cosmed K5, while it was being repaired. One participant 
completed visit 1 and 2 using the Cosmed Fitmate Pro, while the other only completed 
visit 1 while using it. While analyzing the data from the Cosmed K5 and Cosmed 
Fitmate Pro, it was determined that the EE measurements reported by the Cosmed 
Fitmate Pro were significantly different than the values reported by the Cosmed K5. 
When EE measurements from the activity monitors were compared to the Cosmed 
Fitmate Pro, they displayed significantly higher %RE and MAPE in comparison to those 
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that were compared to the Cosmed K5. Therefore, all data that was collected and 
compared to the Cosmed Fitmate Pro was excluded from the Results. 
Some data loss also occurred for the Dexcom G5 CGM, as was expected based 
on our prior experience with this technology (sensor, transmitter, and receiver Bluetooth 
communication loss sometimes occurs). One participant, who only completed visit 1, did 
not provide access to their glucose data, so their glucose data could not be analyzed. 
Two participants experienced issues with the glucose sensor and transmitter properly 
reporting glucose data to the Dexcom G5 app on their smartphone, which resulted in a 
lot of missing data. For one participant, there was missing glucose data during and for 
12 hours post-exercise for visit 1 and for 12 hours post-exercise for visit 2, while there 
was missing data for another participant during the 12 hours post-exercise following visit 
2. Consequently, due to all the missing data, the glucose data for these subjects during 
these periods could not be analyzed and was excluded from the Results. In addition, the 
glucose sensor that was inserted into the skin became loose and came out of the skin in 
two participants by the end of visit 2. As a result, no glucose data was collected for 
these participants for the 12 hours post-exercise following visit 2. 
 
5.2.3. Energy Expenditure Accuracy 
Both the FI and GV3 performed reasonably well at measuring EE overall, but a 
considerable positive bias (i.e. overestimation) was displayed during resistance exercise 
on both devices. Table 13 presents pooled EE data from each exercise for the FI and 
the GV3. 
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The FI displayed a significant overestimation in total EE measurements during 
resistance exercise (Cosmed: 164.2 ± 47.0 kcal, FI: 249.3 ± 93.6 kcal, P<0.01) and a 
significant underestimation in EE during HIIT-T (Cosmed: 257.8 ± 51.3 kcal, FI: 231.5 ± 
57.7, P<0.05) compared to the Cosmed K5 (Figure 8). 
The correlational relationships in EE measurements between Cosmed and the 
consumer-grade devices ranged from 0.58 to 0.92 for the FI and 0.04 to 0.89 for the 
GV3 (Table 13). The FI had the strongest correlation with Cosmed during VO2 peak-T 
(r=0.92) and the weakest correlation during HIIT-C (r=0.58), while the GV3 also had the 
strongest correlation with Cosmed during VO2 peak-T (r=0.89) and the weakest 
correlation during resistance exercise (r=0.04). 
Correlation plots for total EE on Cosmed and total EE on the FI and GV3 
demonstrated an overestimation in EE measurements on the FI during resistance 
exercise in both T1D and control subjects (Figure 9C). In addition, T1D subjects 
displayed an overestimation in EE measurements during both resistance exercise and 
HIIT-C on the GV3 compared to the control subjects, as seen by the separation of each 
group’s EE values from the other on the plots (Figure 9D and 9J). 
MAPE ± SD for the FI and GV3 was 27.5 ± 27.9% and 27.0 ± 25.0%, respectively 
(Figure 10). The lowest MAPE in EE was observed during HIIT-T (11.0 ± 6.6%) for the 
FI and VO2 peak (16.4 ± 11.2%) for the GV3. The highest MAPE was observed during 
resistance exercise for both devices (FI: 56.1 ± 44.4%, GV3: 44.6 ± 34.3%). 
Mean relative percentage error displayed a positive bias in EE measurements for 
the FI and GV3 compared to Cosmed, with the FI displaying a greater positive bias 
overall (FI: 15.7 ± 36.0%, GV3: 7.0 ± 36.3%) (Figure 11). The lowest %RE in measuring 
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EE was observed during VO2 peak (7.4 ± 22.6%), HIIT-T (-7.8 ± 10.5%), and HIIT-C 
(6.8 ± 32.9%) for the FI and HIIT-T (-2.2 ± 26.1%) for the GV3. The highest %RE was 
observed during resistance exercise for both devices (FI: 56.1 ± 44.4%, GV3: 28.6 ± 
49.7%). There was a significant difference in %RE of EE measurements during VO2 
peak between the FI and GV3 (FI: 7.4 ± 22.6%, GV3: -4.6 ± 19.9%, P<0.05). 
Bland-Altman plots demonstrated a positive bias in EE measurements on the FI 
with a mean difference of 19.8 ± 65.1 kcal, while the GV3 displayed only a small 
positive bias in EE with a mean difference of 1.9 ± 72.0 kcal when compared to Cosmed 
(Figure 12). However, the plots revealed narrower 95% LoA for the FI (difference: 255.4 
kcal) compared to the GV3 (difference: 282.4 kcal). In addition, the plots indicated that 
the greatest difference in EE measurements on the FI occurred during resistance 
exercise, as demonstrated by almost all of the EE values lying outside the LoA when 
resistance exercise was performed (Figure 12A). 
Both the FI and GV3 demonstrated a negative bias for exercise performed on the 
treadmill (FI: -0.2 ± 18.9%, GV3: -3.4 ± 22.9%) and a positive bias for exercise 
performed on the cycle ergometer (FI: 6.8 ± 32.9%, GV3: 5.8 ± 43.1%) (Figure 13). 
However, there was no significant difference between the FI and GV3 in %RE of EE 
during treadmill and cycling exercises. 
A significant difference in %RE in EE was displayed by the GV3 between T1D 
and control subjects (T1D: 22.6 ± 35.4%; Control: -15.6 ± 24.0%, P<0.0001), but no 
such difference was exhibited by the FI (T1D: 13.5 ± 35.8%; Control: 19.5 ± 37.0%) 
(Figure 14). The FI displayed a positive bias in %RE in EE in both T1D and control 
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subjects, while the GV3 displayed a positive bias in individuals with T1D and a negative 
bias in control subjects. 
The GV3 demonstrated a positive bias in EE for individuals with T1D during all 5 
exercises performed compared to control subjects, with a significant difference between 
groups during resistance exercise (T1D: 58.5 ± 37.7%, Control: -7.4 ± 37.8%, P<0.05), 
ADL (T1D: 23.3 ± 37.8%, Control:-12.0 ± 14.4%, P<0.05), and HIIT-C (T1D: 32.7 ± 
32.5%, Control: -34.6 ± 13.8%, P<0.01) (Appendix G). 
There were no significant differences in most anthropometric measures between 
T1D and control subjects, albeit our sample size was small, with the exception of the 
Fitzpatrick skin tone score and BF%. Individuals with T1D had significantly higher mean 
scores on the Fitzpatrick skin tone scale (T1D: 2.6 ± 0.5, Control: 2.0 ± 0.0, P<0.05) and 
higher BF% (T1D: 26.9 ± 9.0, Control: 17.7 ± 5.1, P<0.05) compared to control subjects 
(Appendix H). 
There was also no significant difference in the %RE of EE measurements 
between dominant hand and non-dominant hand wear for either the FI or the GV3 
(Appendix I). 
Moderate or strong relationships were not displayed between %RE for the 
devices and most of the anthropometrics measured (Appendix J). However, a 
moderate, positive relationship was displayed between %RE in EE for the GV3 and 
BF% (r=0.52, P<0.0001) (Appendix JJ) and a moderate, negative relationship was 
displayed between %RE for the GV3 and VO2 peak (r=-0.40, P<0.01) (Appendix JX). 
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5.2.4. Glucose 
Blood glucose and interstitial glucose concentrations were monitored in all 
individuals with T1D before, during, and for 12-hours post-exercise using SMBG and 
CGM, respectively. Two control subjects also agreed to monitor their glucose before, 
during, and immediately after exercise using SMBG and CGM. Only one of those 
control subjects agreed to wear a CGM system for 12-hours post-exercise to monitor 
their interstitial glucose. 
Both T1D and control subjects displayed a decrease in mean BG from pre- to 
post-exercise during both visits, with the greatest change occurring in individuals with 
T1D during visit 1 (Figure 15). A mean decrease of 2.6 ± 3.8 mmol/L in BG was 
observed in individuals with T1D from pre- to post-exercise (Pre: 9.7 ± 3.2 mmol/L, 
Post: 7.2 ± 2.0 mmol/L, n=9) in visit 1, while a mean decrease of 1.3 ± 2.8 mmol/L was 
observed from pre- to post-exercise (Pre: 9.0 ± 1.8 mmol/L, Post: 7.7 ± 2.2 mmol/L, 
n=8) in visit 2. A mean decrease of 0.6 ± 0.1 and 1.6 ± 0.3 mmol/L was observed in the 
control subjects from pre- to post-exercise in visit 1 (Pre: 6.3 ± 0.8 mmol/L, Post: 5.7 ± 
0.7 mmol/L, n=2) and in visit 2 (Pre: 6.9 ± 0.1 mmol/L, Post: 5.3 ± 0.4 mmol/L, n=2), 
respectively. 
For individual exercises, the largest mean change in BG occurred during HIIT-C 
for individuals with T1D and during ADL for control subjects (Figure 16). In visit 1, 
individuals with T1D exhibited a mean increase of 0.9 ± 2.1 mmol/L in BG during the 
VO2 peak test, followed by a mean decrease of 0.8 ± 2.0 and 2.1 ± 2.5 mmol/L in BG 
during resistance exercise and HIIT-C, respectively. Control subjects displayed a mean 
change in BG of 1.3 ± 2.0 mmol/L during VO2 peak, -0.3 ± 0.2 mmol/L during resistance 
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exercise, and 0.5 ± 1.3 mmol/L during HIIT-C. In visit 2, a mean decrease of 0.1 ± 0.9 
and 0.8 ± 1.6 mmol/L in BG was observed in individuals with T1D during ADL and HIIT-
T, respectively, while control subjects displayed a mean decrease in BG of 2.6 ± 0.6 
mmol/L during ADL and 0.4 ± 0.1 mmol/L during HIIT-T. A maximum change in BG of 
7.3 mmol/L was observed in the T1D subjects during exercise, while only a maximum 
change of 3.0 mmol/L was observed in the control subjects. 
Based on interstitial glucose levels as measured by CGM, individuals with T1D 
spent more time in euglycemia during and following visit 2 compared to visit 1, while 
control subjects were in euglycemia almost 100% of the time during and following both 
visits (Figure 17). Mean percent time in euglycemia during exercise was 54% and 86%, 
time in hypoglycemia was 6% and 0%, and time in hyperglycemia was 40% and 14% in 
individuals with T1D during visit 1 and 2, respectively. Mean percent time in euglycemia 
during exercise for control subjects was 100% in both visits. For 12 hours post-exercise, 
mean percent time in euglycemia was 59% and 66%, time in hypoglycemia was 6% and 
3%, and time in hyperglycemia was 34% and 31% in individuals with T1D following visit 
1 and 2, respectively. One control subject agreed to wear the CGM system for 12 hours 
post-exercise and their percent time in euglycemia was 100% for 12 hours post-
exercise after visit 1 and 92% after visit 2, with the remaining 8% of time spent in 
hypoglycemia. 
Following visit 1, the glucose levels in most individuals with T1D remained 
relatively stable and within the glucose target range (i.e. 3.9-10.0 mmol/L) for these 
individuals for ~3-4 hours post-exercise. After 4 hours, mean interstitial glucose 
exceeded 10 mmol/L and remained elevated in the hyperglycemic range for 2 hours 
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before returning to and staying in euglycemia for the next 6 hours. Following visit 2, 
mean interstitial glucose remained in target for 5.5 hours. Mean interstitial glucose 
entered hyperglycemia for ~1.5 hours, returned to euglycemia for ~1 hour, before 
returning to and staying in a hyperglycemic range for the next 5 hours, although there 
was large variability between subjects during this 5-hour period. For one control subject, 
interstitial glucose remained in euglycemia for the entire 12 hours post-exercise 
following visit 1. Following visit 2, interstitial glucose for the control subject was in 
euglycemia for ~2 hours, before entering hypoglycemia for ~1 hour, and then returning 
to and remaining stable in euglycemia for the next 9 hours (Figure 18). 
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6. DISCUSSION 
6.1. PRINCIPAL FINDINGS 
This project examined the accuracy of four wrist-worn, consumer-grade activity 
monitors at measuring EE during a variety of physical activities. Similar to previous 
studies (27,34,38,40,41,50,51,53), all four activity monitors tested displayed a high 
overall MAPE in EE measurements, ranging from 25-28%. The GVHR+ (-1.6%) and the 
GV3 (7.0%) were the only two devices to display a %RE of 10%, while the FC2 (-
19.3%) and FI (15.7%) displayed a %RE of >10%. The FC2 displayed a significant 
underestimation in EE measurements during cycling, while the FI, GVHR+, and GV3 all 
displayed an overestimation in EE during resistance exercise. The GV3 significantly 
overestimated EE in individuals with T1D compared to individuals without T1D. A 
greater mean decrease in BG was observed in individuals with T1D during exercise visit 
1 compared to visit 2. There was a mean decrease in BG in individuals with T1D during 
all activities, except during the VO2 peak test where they displayed a mean increase in 
BG. 
The FC2 displayed a significantly higher MAPE (42.7%) during cycling than any 
other device tested and a significant underestimation in EE measurements (-40.5%) 
during cycling activities compared to other activities, which was not exhibited in the 
other three activity monitors assessed. Boudreaux et al. (53) observed the highest 
MAPE (75%) for the FC2 out of seven devices tested during cycling with an 
underestimation in EE in 80% of subjects. They also assessed the Garmin vívosmart 
HR, an earlier model to the GVHR+, which displayed no significant difference in EE 
measurements compared to indirect calorimetry, similar to our findings (53). 
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The FI (56.1%), GVHR+ (21.0%), and GV3 (28.6%) all displayed a greater %RE 
and greater overestimation in EE during resistance exercise compared to all other 
activities. These findings were similar to the findings by Boudreaux et al. (53), who 
observed an overestimation in EE in 60-90% of subjects by all seven devices tested 
during resistance exercise, but were contradictory to the findings by Bai et al. (40), who 
observed an underestimation in EE measurements by four different activity monitors. 
However, Bai et al. (40) observed higher inaccuracy in EE measurements by all devices 
during resistance exercise compared to aerobic exercise and sedentary activities. 
There are a number of factors that can affect the accuracy of EE measurements 
by activity monitors, including the device wear location and the algorithms used to 
calculate EE. In addition, the ability of the reference standard to accurately measure 
anaerobic metabolism should be considered when comparing activity monitors to 
reference standards during exercise. 
The location at which an activity monitor is worn during different types of activity 
can affect the accuracy of EE measurements, with some devices displaying decreased 
accuracy on upper limbs compared to lower limbs. Some activities, such as cycling and 
resistance exercise, may require some limbs to be active, while others remain inactive. 
If activity monitors are being worn on limbs that are primarily inactive, no movement will 
be detected by the built-in accelerometers, which could result in the activity monitors 
reporting an underestimation in EE. Although an underestimation in EE was not 
displayed during resistance exercise by most of the devices tested, the FC2 displayed 
underestimation during both cycling and resistance exercise. The FC2 is a wrist-worn 
activity monitor and little to no arm movement was required for cycling and some of the 
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exercises in our resistance protocol. Studies have observed greater accuracy in EE by 
research-grade activity monitors worn at the waist compared to those worn at the wrist 
or ankle during resistance exercise, due to the lack of consistent upper or lower limb 
movement occurring during resistance exercise (92,93). The lack of arm movement 
detected by the FC2’s built-in accelerometer may have resulted in the underestimation 
in EE that was observed during cycling and resistance exercise. Although the 
algorithms being used are proprietary and there is no way of knowing for certain, the 
FC2 may be relying heavily on accelerometry data to calculate EE, which may not be 
effective for measuring EE during cycling, resistance, and other exercises that involve 
more lower limb movement and require little to no upper limb movement. 
Since the EE algorithms being used by consumer-grade activity monitors are 
proprietary, it is difficult to know how EE is being calculated and how EE measurement 
accuracy can be improved. Despite the algorithms being proprietary, Fitbit and Garmin 
both use age, height, weight, and sex to estimate EE in all of their devices (94,95). 
However, incorporating other anthropometrics into EE algorithms may help to further 
improve EE measurement accuracy by these activity monitors. For example, Plasqui et 
al. (96) determined that incorporating lean body mass and fat mass into EE 
measurements from a research-grade activity monitor during physical activity improved 
the accuracy of EE measurements. Incorporating these and other anthropometrics into 
EE algorithms may also help to improve the accuracy of consumer-grade activity 
monitors at measuring EE. Consumer-grade activity monitor manufacturers, such as 
Fitbit and Garmin, may be using use other inputs to measure EE, but these inputs are 
undisclosed. 
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Although the FC2 underestimated EE, the FI, GVHR+, and GV3 all 
overestimated EE during resistance exercise. Due to the brief, intense bouts of activity 
performed during resistance exercise, it is considered to be an anaerobic activity in 
nature. Therefore, using aerobic measurement tools, such as indirect calorimetry, to 
measure EE during this activity may not be appropriate. Only measuring aerobic 
metabolism and not accounting for anaerobic metabolism during anaerobic activities will 
likely result in an underestimation in EE measurements (97). If there is an 
underestimation in EE measurements by the reference standard (i.e. indirect 
calorimeter) that the activity monitors are being compared against, it may make it seem 
as though the activity monitors are significantly overestimating EE, when in fact, their 
EE measurements may be more accurate than they appear. Scott (97) suggested that 
measuring excess post-exercise oxygen consumption (EPOC) may be a more effective 
method for assessing EE for resistance exercise than only measuring oxygen 
consumption during this activity. Vezina et al. (98) applied this to EE measurements 
taken by an indirect calorimeter during resistance exercise and compared them to 
EPOC-adjusted EE measurements. They discovered that EPOC-adjusted EE 
measurements were significantly higher than non-adjusted EE measurements taken 
from indirect calorimetry (P<0.001) (98). If the EPOC-adjusted EE measurements are 
higher than the non-adjusted EE measurements from indirect calorimetry, then the 
magnitude of error between the EPOC-adjusted EE measurements and the EE 
measurements from activity monitors will decrease, and the activity monitors may no 
longer display a significant overestimation in EE measurements during resistance 
exercise. 
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An unexpected finding of Study B was the discovery of a significant 
overestimation in EE measurements by the GV3 in individuals with T1D compared to 
individuals without T1D. No other study to date has assessed the difference in accuracy 
of activity monitors between individuals with and without T1D. This observation needs to 
be examined in more detail prior to incorporating any activity monitor into an AP system 
since it may make insulin dosing less accurate if EE is not measured accurately. 
Specifically, less insulin delivery would normally be initiated by an AP system as EE 
increases, at least to a point (25), since muscle contraction/exercise is known to recruit 
non-insulin-mediated glucose transport (99) and increase the risk of hypoglycemia in 
individuals with T1D (25). In other words, if activity monitors are incorporated into AP 
systems under the assumption that they will provide the same level of accuracy in 
individuals with T1D as individuals without T1D, and they do not, it may affect the 
accuracy of the AP system and cause it to make inaccurate decisions. In this case, it is 
difficult to know exactly why the GV3 overestimated EE in individuals with T1D. 
Upon examination, it was discovered that the individuals with T1D in Study B had 
a significantly higher BF% and a darker skin tone score on the Fitzpatrick skin tone 
scale than individuals without T1D. As previously discussed, different anthropometrics, 
such as lean body mass and fat mass, can affect the accuracy of activity monitors at 
measuring EE (96). Although no relationship was observed between lean body mass 
and accuracy in EE in this study, there was an overall moderate, positive relationship 
displayed between %RE in EE for the GV3 and BF% (r=0.52, P<0.0001), indicating that 
those with a higher BF% tended to display a greater overestimation in EE by the GV3 
compared to those with a lower BF%. If Garmin were to incorporate BF% into their EE 
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algorithms, it may result in improvements in the EE measurements by the GV3. In 
addition, studies examining the accuracy of HR measurements by PPG sensors in wrist-
worn activity monitors have discovered greater error in HR measurements in individuals 
with darker skin tones (46,100). Garmin states that their devices that measure HR, such 
as the GV3, use HR to help calculate EE (95). If the findings from previous studies are 
also true for the GV3, then the darker skin tones in individuals with T1D may be 
producing higher error in HR measurements, which could be affecting the accuracy of 
the EE measurements produced by the GV3 and contributing to the difference in EE 
accuracy displayed between the two groups of subjects. 
Furthermore, PPG sensors used in wrist-worn activity monitors, such as the GV3, 
measure HR by flashing a light-emitting diode (LED) light through the skin to detect the 
contraction and dilation of arteries in the wrist with each pulse (101). Studies have 
demonstrated an increase in endothelial dysfunction exhibited by decreased flow-
mediated dilation (widening of arteries in response to increased blood flow) of the 
brachial artery and the capillaries in fingertips of children, adolescents, and young 
adults with T1D (102–105). Since PPG sensors are measuring the contraction and 
dilation of arteries, the impaired vasodilatory response present in individuals with T1D 
may be affecting the ability of the PPG sensors in the GV3 to accurately measure HR 
and producing greater error in HR measurements. This could consequently be 
impacting the accuracy of the EE measurements produced by the GV3 and causing the 
overestimation in EE displayed by the GV3 in individuals with T1D. 
Although no other study has examined the effects of the combination of activities 
performed in Study B on BG, it was predicted that a greater decrease in BG 
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concentration would be observed during visit 1 compared to visit 2, based on the 
response observed to these activities in individuals with T1D in previous studies (58–
63). In visit 1, a greater mean decrease of 2.6 ± 3.8 mmol/L in BG was observed after 
completing three different moderate- to vigorous-intensity exercises, while in visit 2, a 
mean decrease of 1.3 ± 2.8 mmol/L in BG was observed after completing one low-
intensity and one high-intensity activity. A mean increase of 1.0 ± 2.0 mmol/L in BG was 
observed during the VO2 peak test in both individuals with and without T1D. This is 
consistent with the findings of Purdon et al. (63), who also examined an increase in BG 
in individuals with and without T1D after completing a VO2 max test, which was 
attributed to the rise in catecholamines observed during this type of vigorous-intensity 
activity. The decrease in BG observed during resistance exercise, HIIT-C, and HIIT-T 
has also been observed in other studies where individuals with T1D performed these 
types of exercises (58–62). The increased glucose uptake that occurs during exercise, 
the exogenous insulin present in the body, and the impaired counterregulatory 
responses in individuals with T1D all contribute to increased glucose utilization by 
muscles and a decrease in BG during exercise in these individuals (106,107). A small 
mean decrease in BG (0.1 ± 0.9 mmol/L) was observed during ADL, which was 
expected since all activities being performed during ADL were at a low-intensity. 
 
6.2. STRENGTHS 
There are three main strengths of this project. While most studies only examine 
the accuracy of activity monitors during steady-state walking and running, this project 
examined the accuracy of activity monitors during 4-5 different types of activity, 
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including graded exercise tests, resistance exercise, ADL, and HIIT. Study B was the 
first study to compare the accuracy of activity monitors between individuals with and 
without T1D, and as a result, a difference in the accuracy of the GV3 between the two 
groups of subjects was observed. Study B was also the first study to examine the 
effects of performing a combination of a VO2 peak test, resistance exercise, and HIIT-C 
on BG and of performing ADL and HIIT-T on BG. 
 
6.3. LIMITATIONS 
Although there are clear strengths of this project, there were also several 
limitations. The first limitation is that both Study A (n=20) and Study B (n=15) were 
underpowered based on our sample size calculations and had a relatively small sample 
size in comparison to other studies that have assessed the accuracy of consumer-grade 
activity monitors, with some studies including up to 62 subjects (34). In addition to the 
small sample size, there was also a lack of diversity in the subjects in both studies. Most 
subjects were between the ages of 18-29, primarily Caucasian, with a normal BMI. 
Consequently, this makes the findings of Study A and Study B less generalizable to the 
rest of the population. Both studies used an in-laboratory exercise protocol, which 
cannot be generalized to free-living conditions. During the resistance exercise, subjects 
were allowed to self-select their weights for resistance during each exercise. This can 
be considered a limitation, because subjects were not required to determine their 1 
repetition-maximum (RM) for each exercise and perform exercises at a specific 
percentage of their 1 RM, meaning the resistance being used was not standardized 
between subjects. However, by allowing subjects to self-select their weights, it made the 
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resistance exercise more generalizable to free-living conditions where subjects would 
self-select their weights based on what they feel comfortable using rather than lifting a 
certain percentage of their 1 RM. Another limitation of this project is that only four 
activity monitors were assessed for accuracy in EE, while some other studies have 
assessed up to nine different activity monitors (39). In addition, there was a lot of data 
loss due to technical challenges (i.e. device connectedness, etc.) that occurred in both 
Study A and Study B. Although we had a total of 15-20 subjects complete each study, 
the data loss that occurred resulted in a much smaller sample of data to analyze for 
certain activities (e.g. n=6 for EE by GVHR+ during VO2 Peak-T). Furthermore, many 
manufacturers do not provide access to minute-by-minute data from their devices, so it 
made it difficult to assess EE data at a higher sample rate for all devices. By not having 
access to this data, it prevented us from examining how accuracy may have changed 
throughout the duration of each activity and limited us to only examining total EE 
accuracy for each activity. By analyzing minute-by-minute data, it would have allowed 
us to determine if there was greater accuracy or error during certain parts of each 
activity and provided a better understanding of why there may have been greater 
accuracy in EE measurements during some activities compared to others. 
 
6.4. FUTURE DIRECTIONS 
Consumer-grade activity monitor accuracy is a relatively new area of research 
and a lot more work still needs to be conducted in this field. The activity monitors 
assessed in this project, as well as all other activity monitors, need to be tested in a 
larger, more diverse group of subjects. While most studies have only assessed activity 
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monitors in laboratory settings, activity monitors should also be examined during 
exercise in free-living conditions. More studies need to assess activity monitor accuracy 
during a variety of non-steady-state activities, such as elliptical exercise, cycling, 
resistance exercise, and different sports. Newer activity monitors are being released to 
the consumer market every year and these newer monitors also need to be assessed 
for accuracy (19). For the purpose of this project, only EE accuracy was assessed. 
However, all metrics measured by activity monitors need to be assessed for accuracy, 
such as HR, steps, etc. When you are working with any type of technology, there is a 
high likelihood of data loss. Researchers need to be aware of all of the possible areas of 
and reasons for data loss to occur and need to make an effort to try and reduce as 
much data loss as possible during these types of studies. Although manufacturers do 
not provide consumers with access to minute-by-minute data, this data can be 
accessed through the third-party, pay for service research platform, Fitabase. 
Previously, Fitabase only provided access to Fitbit data at a higher sample rate than 
what was available to consumers from Fitbit, but recently, they have begun providing 
access to Garmin data as well. Although acquiring a subscription is expensive, if 
researchers are able to, they should acquire a subscription to Fitabase, so that they can 
access and analyze activity monitor data at a higher sample rate than what is provided 
by the manufacturer. This will be especially useful for analyzing HR data from Fitbit and 
Garmin devices. 
Based on the findings from Study A and Study B, there are a number of things 
that should be examined in future studies. The underestimation in EE displayed by the 
FC2 during cycling and resistance exercise needs to be examined further. However, 
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since Study A was conducted, Fitbit has released an updated model of the FC2 to 
consumers, known as the Fitbit Charge 3 (FC3). Future studies should examine the 
FC3 to see if the underestimation in EE measurements that was observed during 
cycling and resistance exercise by the FC2 also exists in the FC3. In addition, 
researchers should examine if there is greater accuracy on the FC3 when subjects are 
performing more upper limb movement compared to when they are performing little to 
no upper limb movement. All previous studies that have examined the accuracy of 
activity monitors have used indirect calorimetry as the reference standard. However, in 
future studies, researchers should consider using EPOC-adjusted EE measurements 
from indirect calorimetry as the reference standard for resistance exercise and any 
other anaerobic activities to avoid displaying inaccurate overestimations in EE by 
activity monitors during these types of activities. More research also needs to be 
conducted using the GV3 in a larger sample of individuals with and without T1D to see if 
the overestimation in EE displayed by the GV3 in Study B persists in individuals with 
T1D compared to those without T1D. Furthermore, more research needs to be done to 
determine if the inaccuracy in EE displayed by the GV3 can be attributed to darker skin 
tones, higher BF%, and decreased flow-mediated dilation in subjects. 
 
6.5. CONCLUSIONS 
The FC2, FI, GVHR+, and GV3 were assessed for accuracy during a variety of 
physical activities. All four activity monitors displayed a MAPE of >10%, while only the 
GVHR+ and GV3 displayed a %RE of 10%. The FC2 displayed a significant 
underestimation in EE measurements during cycling, while the FI, GVHR+, and GV3 all 
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displayed an overestimation in EE during resistance exercise. Although the GVHR+ and 
GV3 displayed a %RE of 10% in measuring EE, the GVHR+ was not assessed in 
individuals with T1D and the GV3 displayed a significant overestimation in EE in 
individuals with T1D compared to individuals without T1D. Therefore, based on the 
findings of this project, none of the devices tested in Study A or Study B can be 
considered accurate enough or ready to be incorporated into an AP system at this time, 
although the GV3 is approaching the accuracy (i.e. 10% %RE) that was initially 
displayed by earlier CGM systems that are now routinely incorporated into AP 
prototypes and Health Canada-approved AP systems. More research needs to be 
conducted with the GV3 in a larger sample of individuals with and without T1D to 
determine if the overestimation in EE observed in this study exists in a larger group of 
subjects with T1D, and if it does exist, it needs to be determined why this overestimation 
is occurring. 
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8. ABBREVIATIONS 
 
ADA   American Diabetes Association 
ADL   Activities of daily living 
ANOVA  Analysis of variance 
AP   Artificial pancreas 
API   Application programming interface 
BF%   Body fat percentage 
BG   Blood glucose 
CGM   Continuous glucose monitoring 
CSII   Continuous subcutaneous insulin infusion 
CVD   Cardiovascular disease 
EE   Energy expenditure 
EPOC   Excess post-exercise oxygen consumption 
FC2   Fitbit Charge 2 
FC3   Fitbit Charge 3 
FI   Fitbit Ionic 
GPS   Global positioning system 
GVHR+  Garmin vívosmart HR+ 
GV3   Garmin vívosmart 3 
HbA1c   Glycated hemoglobin 
HIIT-C  High-intensity interval training on a cycle ergometer 
HIIT-T   High-intensity interval training on a treadmill 
HR   Heart rate 
HRR   Heart rate reserve 
HSD   Honestly significant difference 
ICC   Intraclass correlation coefficient 
IPAQ   International Physical Activity Questionnaire 
LED   Light-emitting diode 
LoA   Limits of agreement 
MAPE   Mean absolute percentage error 
MDI   Multiple daily injections 
METs   Metabolic equivalents 
PAR-Q+  Physical Activity Readiness Questionnaire for Everyone 
PPG   Photoplethysmography 
RM   Repetition-maximum 
RPE   Rating of perceived exertion 
SMBG  Self-monitoring of blood glucose 
T1D   Type 1 diabetes 
T1DEXI  Type 1 Diabetes and Exercise Initiative 
T2D   Type 2 diabetes 
VCO2   Volume of carbon dioxide production 
VO2   Volume of oxygen consumption 
VO2 max  Maximum volume of oxygen consumption 
VO2 Peak  Peak volume of oxygen consumption 
VO2 Peak-C  Progressive aerobic exercise test on a cycle ergometer 
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VO2 Peak-T  Progressive aerobic exercise test on a treadmill 
WC   Waist circumference 
%RE   Mean relative percentage error 
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9. TABLES & FIGURES 
 
9.1. SUMMARY OF THE SCIENTIFIC LITERATURE 
 
Table 1. Summary of Literature on Accuracy of Activity Monitors for Walking. Summary of the 
existing scientific literature on accuracy of consumer-grade activity monitors at measuring energy 
expenditure compared to indirect calorimetry for walking. 
 
Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE 
Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
ICC 
Alsubheen 
et al. (2016) 
(42) 
Walking 
at 0% 
incline 
Garmin 
vívofit 
Wrist 
-45%      
Walking 
at 5% 
incline 
-30%      
Walking 
at 10% 
incline 
-18%      
Chowdhury 
et al. (2017) 
(38) 
Walking 
at 2.5 or 3 
mph 
Apple 
Watch 
Wrist  24%     
Fitbit 
Charge HR 
Wrist  73%     
Jawbone 
UP24 
Wrist  27%     
Microsoft 
Band 
Wrist  37%     
Walking 
at 2.5 or 3 
mph with 
weighted 
bags (6kg 
for 
females, 
10kg for 
males) 
Apple 
Watch 
Wrist  14%     
Fitbit 
Charge HR 
Wrist  48%     
Jawbone 
UP24 
Wrist  14%     
Microsoft 
Band 
Wrist  49%     
Diaz et al. 
(2015) (37) 
Walking 
at 3 mph 
Fitbit Flex Wrist 
52%      
Walking 
at 4 mph 
33%      
Diaz et al. 
(2016) (36) 
Walking 
at 1.9 
mph 
Fitbit Flex Wrist 83%      
Fitbit One Hip -8%      
Fitbit One 
Upper 
Torso 
-10%      
Walking 
at 3 mph 
Fitbit Flex Wrist 68%      
Fitbit One Hip 13%      
Fitbit One 
Upper 
Torso 
18%      
Walking 
at 4 mph 
Fitbit Flex Wrist 29%      
Fitbit One Hip 12%      
Fitbit One 
Upper 
Torso 
20%      
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Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE 
Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
ICC 
Dondzila & 
Garner 
(2016) (35) 
Walking 
at 3 mph 
Fitbit 
Charge 
Wrist 21%      
Jabra 
Sport 
Pulse 
Earbuds 
Ear -27%      
Walking 
at 4 mph 
Fitbit 
Charge 
Wrist -11%    0.52  
Jabra 
Sport 
Pulse 
Earbuds 
Ear -10%    0.52  
Dooley et al. 
(2017) (34) 
Walking 
at 2.5 
mph 
Apple 
Watch 
Wrist  20%     
Fitbit 
Charge HR 
Wrist  85%     
Garmin 
Forerunner 
225 
Wrist  78%     
Walking 
at 3.5 
mph 
Apple 
Watch 
Wrist  14%     
Fitbit 
Charge HR 
Wrist  46%     
Garmin 
Forerunner 
225 
Wrist  74%     
Gusmer et 
al. (2014) 
(33) 
Slow 
walking 
(avg. 
speed: 
2.5 mph) 
Fitbit Ultra Hip 
    0.69  
Brisk 
walking 
(avg. 
speed: 
3.0 mph) 
    0.94  
Nelson et al. 
(2016) (50) 
Self-
paced 
walking 
(avg. 
speed: 
2.9 mph) 
Fitbit Flex Wrist  53%     
Fitbit One Hip  31%     
Fitbit Zip Hip  68%     
Jawbone 
UP24 
Wrist  24%     
Noah et al. 
(2013) (49) 
Walking 
(3.5 mph, 
0% 
incline) 
Fitbit Hip      0.70 
Fitbit Ultra Hip      0.83 
Walking 
(3.5 mph, 
5% 
incline) 
Fitbit Hip      0.72 
Fitbit Ultra Hip      0.81 
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Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE 
Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
ICC 
Pribyslavska 
(2018) (43) 
Walking 
at 
moderate-
intensity 
(40-59% 
HRR) 
Fitbit 
Surge 
Wrist -4% 14%     
Garmin 
vívofit 
Wrist -12% 20%     
Price et al. 
(2017) (48) 
Walking 
at 1.6-4.0 
mph and 
1% incline 
Fitbit One Hip   
2.2 
kcal/min 
-2.3 to 
6.8 
kcal/min 
0.73  
Garmin 
vívofit 
Wrist   
-1.7 
kcal/min 
-4.1 to 
0.7 
kcal/min 
0.71  
Jawbone 
UP 
Wrist   -2.1 kcal 
-21.9 to 
17.7 
kcal 
0.72  
Sasaki et al. 
(2015) (47) 
Walking 
at 3 mph 
Fitbit Hip 
-22%      
Walking 
at 4 mph 
- ~35%      
Walking 
with 
weighted 
bags (4 lb 
each) 
~40%      
Stackpool et 
al. (2014) 
(45) 
Self-
paced 
walking 
(3.0-4.2 
mph) 
Adidas 
miCoach 
Not 
reported 
34%    0.53  
BodyMedia 
FIT CORE 
Not 
reported 
    0.68  
Fitbit Ultra 
Not 
reported 
    0.24  
Jawbone 
UP 
Not 
reported 
    0.87  
Nike 
FuelBand 
Not 
reported 
    0.49  
Thiebaud et 
al. (2018) 
(44) 
Walking 
at 2 mph 
Fitbit 
Surge 
Wrist 45%  2.7 kcal 
4.9 to 
12.5 
kcal 
0.52  
Microsoft 
Band 
Wrist -9%  -0.7 kcal 
2.0 to 
8.8 kcal 
0.19  
TomTom 
Cardio 
Wrist 0.4%  0.1 kcal 
2.7 to 
9.6 kcal 
0.57  
Walking 
at 3 mph 
Fitbit 
Surge 
Wrist 62%  10.3 kcal 
19.2 to 
36.4 
kcal 
0.53  
Microsoft 
Band 
Wrist -4%  -0.9 kcal 
7.8 to 
24.7 
kcal 
0.24  
TomTom 
Cardio 
Wrist 12%  2.2 kcal 
11.9 to 
26.6 
kcal 
0.70  
Walking 
at 4 mph 
Fitbit 
Surge 
Wrist 53%  17.0 kcal 
38.6 to 
63.4 
kcal 
0.55  
Microsoft 
Band 
Wrist -2%  -1.3 kcal  0.15  
TomTom 
Cardio 
Wrist 3%  1.0 kcal 
17.8 to 
47.4 
kcal 
0.66  
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Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE 
Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
ICC 
Wahl et al. 
(2017) (39) 
Walking 
at 2.7 
mph 
Beurer 
AS80 
Wrist 17%   
-12.9 to 
18.1 
kcal 
 -0.17 
Fitbit 
Charge 
Wrist 75%   
7.4 to 
26.8 
kcal 
 0.15 
Fitbit 
Charge HR 
Wrist 83%   
4.2 to 
35.0 
kcal 
 0.17 
Garmin 
Forerunner 
920XT 
Wrist -27%   
-21.1 to 
8.0 kcal 
 0.35 
Garmin 
vívoactive 
Wrist 4%   
-5.0 to 
6.4 kcal 
 0.85 
Garmin 
vívofit 
Wrist 1%   
-8.2 to 
8.1 kcal 
 0.73 
Garmin 
vívosmart 
Wrist 3%   
-5.0 to 
6.5 kcal 
 0.91 
Polar Loop Wrist 56%   
-6.4 to 
29.5 
kcal 
 -0.11 
Withings 
Pulse Ox 
Hip -10%   
-14.6 to 
7.8 kcal 
 0.44 
Withings 
Pulse Ox 
Wrist -11%   
-13.9 to 
6.6 kcal 
 0.28 
Walking 
at 4.3 
mph 
Beurer 
AS80 
Wrist -19%   
-33.5 to 
12.0 
kcal 
 -0.09 
Fitbit 
Charge 
Wrist 34%   
-8.2 to 
37.2 
kcal 
 0.29 
Fitbit 
Charge HR 
Wrist 18%   
-7.3 to 
22.9 
kcal 
 0.58 
Garmin 
Forerunner 
920XT 
Wrist -17%   
-33.4 to 
15.5 
kcal 
 0.25 
Garmin 
vívoactive 
Wrist 37%   
-15.3 to 
48.3 
kcal 
 0.28 
Garmin 
vívofit 
Wrist 19%   
-20.2 to 
35.5 
kcal 
 0.35 
Garmin 
vívosmart 
Wrist 36%   
-20.4 to 
51.6 
kcal 
 0.21 
Polar Loop Wrist 54%   
-23.1 to 
67.6 
kcal 
 0.02 
Withings 
Pulse Ox 
Hip 19%   
-31.5 to 
48.1 
kcal 
 -0.15 
Withings 
Pulse Ox 
Wrist 17%   
-36.8 to 
44.5 
kcal 
 -0.15 
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Table 2. Summary of Literature on Accuracy of Activity Monitors for Running. Summary of the 
existing scientific literature on accuracy of consumer-grade activity monitors at measuring energy 
expenditure compared to indirect calorimetry for running. 
 
Authors Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
ICC 
Chowdhury 
et al. (2017) 
(38) 
Running 
at 5.2 
mph 
Apple 
Watch 
Wrist  22%     
Fitbit 
Charge HR 
Wrist  16%     
Jawbone 
UP24 
Wrist  29%     
Microsoft 
Band 
Wrist  18%     
Diaz et al. 
(2016) (36) 
Running 
at 5.2 
mph 
Fitbit Flex Wrist 25%      
Fitbit One Hip -3%      
Fitbit One 
Upper 
Torso 
11%      
Dondzila & 
Garner 
(2016) (35) 
Running 
at 5 mph 
Fitbit 
Charge 
Wrist -14%      
Jabra 
Sport 
Pulse 
Earbuds 
Ear -16%    0.51  
Running 
at 6 mph 
Fitbit 
Charge 
Wrist -23%      
Jabra 
Sport 
Pulse 
Earbuds 
Ear -23%      
Dooley et al. 
(2017) (34) 
Running 
at 5.5 
mph 
Apple 
Watch 
Wrist  17%     
Fitbit 
Charge HR 
Wrist  20%     
Garmin 
Forerunner 
225 
Wrist  31%     
Kendall et 
al. (2019) 
(52) 
Graded 
maximal 
test 
Basis B1 Wrist      0.80 
Fitbit Flex Wrist      0.81 
Jawbone 
UP 
Hip      0.75 
OMRON 
HJ-321 
Hip      0.83 
Polar FT7 Chest      0.74 
Nelson et al. 
(2016) (50) 
Self-
paced 
running 
(avg. 
speed: 
4.5 mph) 
Fitbit Flex Wrist  35%     
Fitbit One Hip  22%     
Fitbit Zip Hip  37%     
Jawbone 
UP24 
Wrist  46%     
  
108 
Authors Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
ICC 
Noah et al. 
(2013) (49) 
Running 
at 5.5 
mph 
Fitbit Hip     0.56  
Fitbit Ultra Hip     0.87  
Pribyslavska 
(2018) (43) 
Running 
at 
vigorous-
intensity 
(60-84% 
HRR) 
Fitbit 
Surge 
Wrist -13%      
Garmin 
vívofit 
Wrist -12% 18%     
Price et al. 
(2017) (48) 
Running 
at 5.0-7.5 
mph and 
1% 
incline 
Fitbit One Hip   
3.6 
kcal/min 
-7.8 to 
14.9 
kcal/min 
  
Garmin 
vívofit 
Wrist   
-1.5 
kcal/min 
-7.7 to 
4.8 
kcal/min 
0.35  
Jawbone 
UP 
Wrist   20.6 kcal 
-37.7 to 
79.0 
kcal 
0.65  
Roos et al. 
(2017) (51) 
Running 
at 30% 
VO2 peak 
Garmin 
Forerunner 
920XT 
Wrist  26%     
Polar V800 Wrist  23%     
Suunto 
Ambit2 
Wrist  42%   0.30  
Running 
at 50% 
VO2 peak 
Garmin 
Forerunner 
920XT 
Wrist  18%     
Polar V800 Wrist  11%     
Suunto 
Ambit2 
Wrist  36%     
Running 
at 70% 
VO2 peak 
Garmin 
Forerunner 
920XT 
Wrist  12%     
Polar V800 Wrist  10%     
Suunto 
Ambit2 
Wrist  21%     
Running 
at 90% 
VO2 peak 
Garmin 
Forerunner 
920XT 
Wrist  38%     
Polar V800 Wrist  30%     
Suunto 
Ambit2 
Wrist  23%     
Running 
at 110% 
VO2 peak 
Garmin 
Forerunner 
920XT 
Wrist  49%     
Polar V800 Wrist  40%     
Suunto 
Ambit2 
Wrist  32%     
Sasaki et al. 
(2015) (47) 
Running 
at 5.5 
mph 
Fitbit Hip - ~5%      
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Authors Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
ICC 
Stackpool et 
al. (2014) 
(45) 
Self-
paced 
running 
(5.0-8.5 
mph) 
Adidas 
miCoach 
Not 
reported 
    0.81  
BodyMedia 
FIT CORE 
Not 
reported 
-13%    0.73  
Fitbit Ultra 
Not 
reported 
    0.63  
Jawbone 
UP 
Not 
reported 
20%    0.69  
Nike 
FuelBand 
Not 
reported 
15%    0.71  
Thiebaud et 
al. (2018) 
(44) 
Running 
at 5 mph 
Fitbit 
Surge 
Wrist 37%  20.7 kcal 
60.8 to 
99.2 
kcal 
0.53  
Microsoft 
Band 
Wrist 4%  1.1 kcal 
34.6 to 
84.7 
kcal 
0.20  
TomTom 
Cardio 
Wrist -16%  -9.5 kcal 
29.7 to 
68.4 
kcal 
0.60  
Running 
at 6 mph 
Fitbit 
Surge 
Wrist 25%  21.7 kcal 
86.6 to 
138.7 
kcal 
0.60  
Microsoft 
Band 
Wrist 8%  5.4 kcal 
61.9 to 
130.3 
kcal 
0.37  
TomTom 
Cardio 
Wrist -27%  -24.0 kcal 
40.5 to 
92.9 
kcal 
0.56  
Wahl et al. 
(2017) (39) 
Running 
at 6.3 
mph 
Beurer 
AS80 
Wrist -33%   
-50.7 to 
6.5 kcal 
 -0.04 
Fitbit 
Charge 
Wrist 14%   
-8.2 to 
21.7 
kcal 
 0.68 
Fitbit 
Charge HR 
Wrist 20%   
-16.4 to 
38.4 
kcal 
 0.43 
Garmin 
Forerunner 
920XT 
Wrist -9%   
-39.8 to 
25.1 
kcal 
 0.25 
Garmin 
vívoactive 
Wrist 20%   
0.8 to 
22.8 
kcal 
 0.69 
Garmin 
vívofit 
Wrist 7%   
-14.1 to 
20.0 
kcal 
 0.76 
Garmin 
vívosmart 
Wrist 24%   
-19.1 to 
48.0 
kcal 
 0.46 
Polar Loop Wrist 51%   
-17.3 to 
68.3 
kcal 
 -0.09 
Withings 
Pulse Ox 
Hip 9%   
-33.0 to 
39.1 
kcal 
 0.27 
Withings 
Pulse Ox 
Wrist 5%   
-32.1 to 
34.3 
kcal 
 0.20 
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Authors Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
ICC 
Wahl et al. 
(2017) (39) 
Running 
at 8.1 
mph 
Beurer 
AS80 
Wrist -43%   
-68.6 to 
1.4 kcal 
 -0.02 
Fitbit 
Charge 
Wrist -0.1%   
-22.3 to 
18.8 
kcal 
 0.73 
Fitbit 
Charge HR 
Wrist 22%   
-22.1 to 
51.5 
kcal 
 0.43 
Garmin 
Forerunner 
920XT 
Wrist -11%   
-50.8 to 
30.5 
kcal 
 0.28 
Garmin 
vívoactive 
Wrist 6%   
-15.6 to 
23.0 
kcal 
 0.82 
Garmin 
vívofit 
Wrist -11%   
-35.9 to 
17.3 
kcal 
 0.56 
Garmin 
vívosmart 
Wrist 9%   
-30.0 to 
42.2 
kcal 
 0.59 
Polar Loop Wrist 41%   
-30.3 to 
76.3 
kcal 
 -0.25 
Withings 
Pulse Ox 
Hip -8%   
-43.5 to 
32.0 
kcal 
 0.54 
Withings 
Pulse Ox 
Wrist -5%   
-37.3 to 
23.4 
kcal 
 0.46 
Outdoor 
running 
at 6.3 
mph 
Beurer 
AS80 
Wrist -48%   
-216.9 
to 1.3 
kcal 
 -0.04 
Fitbit 
Charge 
Wrist -5%   
-75.6 to 
46.2 
kcal 
 0.64 
Fitbit 
Charge HR 
Wrist -12%   
-99.5 to 
40.2 
kcal 
 0.53 
Garmin 
Forerunner 
920XT 
Wrist -21%   
-124.5 
to 29.3 
kcal 
 0.34 
Garmin 
vívoactive 
Wrist -5%   
-46.2 to 
24.3 
kcal 
 0.91 
Garmin 
vívofit 
Wrist -20%   
-86.6 to 
-1.9 kcal 
 0.56 
Garmin 
vívosmart 
Wrist -2%   
-66.8 to 
59.0 
kcal 
 0.82 
Polar Loop Wrist 22%   
-94.8 to 
163.0 
kcal 
 -0.18 
Withings 
Pulse Ox 
Hip -6%   
-132.2 
to 97.3 
kcal 
 0.21 
Withings 
Pulse Ox 
Wrist -5%   
-130.4 
to 91.7 
kcal 
 0.22 
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Table 3. Summary of Literature on Accuracy of Activity Monitors for Elliptical Exercise. Summary 
of the existing scientific literature on accuracy of consumer-grade activity monitors at measuring energy 
expenditure compared to indirect calorimetry for elliptical exercise. 
 
Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE 
Pearson 
Correlation 
Stackpool et 
al. (2014) (45) 
Self-paced 
exercise on 
elliptical cross-
trainer 
BodyMedia 
FIT CORE 
Not reported -20% 0.47 
Fitbit Ultra Not reported  0.41 
Jawbone UP Not reported  0.40 
Nike FuelBand Not reported -27% 0.08 
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Table 4. Summary of Literature on Accuracy of Activity Monitors for Cycling. Summary of the 
existing scientific literature on accuracy of consumer-grade activity monitors at measuring energy 
expenditure compared to indirect calorimetry for cycling. 
 
Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE 
Median 
Absolute 
% Error 
ICC 
Boudreaux 
et al. (2018) 
(53) 
Graded 
exercise 
test on 
cycle 
ergometer 
Apple 
Watch 2 
Wrist  21%  0.23 
Fitbit 
Blaze 
Wrist  72%  0.20 
Fitbit 
Charge 2 
Wrist  75%  0.18 
Garmin 
vívosmart 
HR 
Wrist  63%  0.41 
Polar 
A360 
Chest  38%  0.28 
Polar H7 Wrist  30%  0.27 
TomTom 
Touch 
Wrist  41%  0.30 
Chowdhury 
et al. (2017) 
(38) 
Steady-
state 
cycling on 
cycle 
ergometer 
(females 
at 75 W, 
males at 
100 W) 
Apple 
Watch 
Wrist  20%   
Fitbit 
Charge 
HR 
Wrist  53%   
Jawbone 
UP24 
Wrist  82%   
Microsoft 
Band 
Wrist  38%   
Nelson et al. 
(2016) (50) 
Self-
paced 
cycling on 
cycle 
ergometer 
Fitbit Flex Wrist  44%   
Fitbit One Hip  43%   
Fitbit Zip Hip  46%   
Jawbone 
UP24 
Wrist  57%   
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Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE 
Median 
Absolute 
% Error 
ICC 
Pribyslavska 
(2018) (43) 
Steady-
state 
cycling at 
moderate-
intensity 
(40-59% 
HRR) 
Fitbit 
Surge 
Wrist -20% 28%   
Garmin 
vívofit 
Wrist -6% 19%   
Steady-
state 
cycling at 
vigorous-
intensity 
(60-84% 
HRR) 
Fitbit 
Surge 
Wrist -23% 28%   
Garmin 
vívofit 
Wrist 0% 16%   
Sasaki et al. 
(2015) (47) 
Steady-
state 
cycling at 
50 W on 
cycle 
ergometer 
Fitbit Hip -104%    
Shcherbina 
et al. (2017) 
(46) 
Steady-
state 
cycling on 
cycle 
ergometer 
at low-
intensity 
(50-100 
W) and 
high-
intensity 
(80-225 
W) 
Apple 
Watch 
Wrist   ~40%  
Basis 
Peak 
Wrist   ~60%  
Fitbit 
Surge 
Wrist   ~25%  
Microsoft 
Band 
Wrist   ~35%  
PulseOn Wrist   ~100%  
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Table 5. Summary of Literature on Accuracy of Activity Monitors for Resistance Exercise. 
Summary of the existing scientific literature on accuracy of consumer-grade activity monitors at 
measuring energy expenditure compared to indirect calorimetry for resistance exercise. 
 
Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
MAPE 
Mean 
Difference 
ICC 
Bai et al. 
(2016) (40) 
Self-
selected 
weights, 
sets, and 
reps 
Fitbit Flex Wrist 32% 25.5 kcal  
Jawbone 
UP24 
Wrist 53% 47.2 kcal  
Misfit Shine Wrist  30.8 kcal  
Nike+ 
FuelBand 
SE 
Wrist  26.3 kcal  
Boudreaux 
et al. (2018) 
(53) 
3 circuits of 
10 reps of 
leg curls, 
chest press, 
leg 
extensions, 
and lat 
pulldowns 
Apple 
Watch 2 
Wrist 43%  0.18 
Fitbit Blaze Wrist 49%  0.14 
Fitbit 
Charge 2 
Wrist 48%  0.08 
Garmin 
vívosmart 
HR 
Wrist 57%  0.18 
Polar A360 Chest 53%  0.13 
Polar H7 Wrist 43%  0.11 
TomTom 
Touch 
Wrist 52%  0.02 
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Table 6. Summary of Literature on Accuracy of Activity Monitors for Sports and Sports-Related 
Exercise. Summary of the existing scientific literature on accuracy of consumer-grade activity monitors at 
measuring energy expenditure compared to indirect calorimetry for sports and sports-related exercise. 
 
Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE 
Mean 
Difference 
95% LoA 
Pearson 
Correlation 
ICC 
Sasaki et 
al. (2015) 
(47) 
Basketball, 
golf, and 
tennis 
Fitbit Hip  -2.1 kcal 
-26.0 to 
22.0 kcal 
  
Stackpool 
et al. 
(2014) (45) 
Basketball-
related 
activities 
Adidas 
miCoach 
Not 
reported 
-60%   0.57  
BodyMedia 
FIT CORE 
Not 
reported 
-18%   0.56  
Fitbit Ultra 
Not 
reported 
-17%   0.67  
Jawbone 
UP 
Not 
reported 
-30%   0.65  
Nike 
FuelBand 
Not 
reported 
-14%   0.47  
Wahl et al. 
(2017) (39) 
Intermittent 
running 
simulating 
a soccer 
game 
Beurer 
AS80 
Wrist -46%  
-82.8 to -
8.8 kcal 
 0.00 
Fitbit 
Charge 
Wrist 2%  
-28.5 to 
30.0 kcal 
 0.58 
Fitbit 
Charge HR 
Wrist 26%  
-27.7 to 
78.1 kcal 
 0.43 
Garmin 
Forerunner 
920XT 
Wrist -9%  
-67.8 to 
46.9 kcal 
 0.22 
Garmin 
vívoactive 
Wrist -1%  
-31.5 to 
29.4 kcal 
 0.74 
Garmin 
vívofit 
Wrist -21%  
-53.5 to 
11.4 kcal 
 0.54 
Garmin 
vívosmart 
Wrist 2%  
-61.6 to 
67.0 kcal 
 0.43 
Polar Loop Wrist 6%  
-42.5 to 
46.5 kcal 
 -0.30 
Withings 
Pulse Ox 
Hip -49%  
-72.1 to 3.7 
kcal 
 0.01 
Withings 
Pulse Ox 
Wrist -39%  
-75.5 to -
14.0 kcal 
 0.11 
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Table 7. Summary of Literature on Accuracy of Activity Monitors for Activities of Daily Living. 
Summary of the existing scientific literature on accuracy of consumer-grade activity monitors at 
measuring energy expenditure compared to indirect calorimetry for activities of daily living. 
 
Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE 
Mean 
Difference 
95% 
LoA 
Pearson 
Correlation 
Bai et al. 
(2018) (41) 
Folding 
laundry, 
sweeping, 
moving light 
boxes, 
stretching, 
and slow 
walking 
Apple 
Watch 
Wrist 4% 23%   0.66 
Fitbit 
Charge 
HR 
Wrist -60% 61%   0.41 
Chowdhury 
et al. 
(2017) (38) 
Loading 
and 
unloading 
dishwasher, 
sweeping, 
and 
ascending 
and 
descending 
stairs 
Apple 
Watch 
Wrist  
29-
34% 
   
Fitbit 
Charge 
HR 
Wrist  
15-
39% 
   
Jawbone 
UP24 
Wrist  
29-
52% 
   
Microsoft 
Band 
Wrist  
45-
62% 
   
Nelson et 
al. (2016) 
(50) 
Standing, 
dusting, 
sweeping, 
vacuuming, 
folding 
laundry, 
making 
bed, picking 
up items 
from floor, 
and 
gardening 
Fitbit 
Flex 
Wrist  21%    
Fitbit 
One 
Hip  27%    
Fitbit Zip Hip  36%    
Jawbone 
UP24 
Wrist  35%    
Sasaki et 
al. (2015) 
(47) 
Dusting, 
gardening, 
laundry, 
raking, and 
vacuuming 
Fitbit Hip   -3.1 kcal 
-11.0 
to 
5.2 
kcal 
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Table 8. Summary of Literature on Accuracy of Activity Monitors for Sedentary Activities. 
Summary of the existing scientific literature on accuracy of consumer-grade activity monitors at 
measuring energy expenditure compared to indirect calorimetry for sedentary activities. 
 
Authors 
Testing 
Protocol 
Device 
Tested 
Wear 
Location 
%RE MAPE 
Mean 
Difference 
Pearson 
Correlation 
Bai et al. 
(2016) 
(40) 
Reading, 
cell phone 
use, typing, 
watching 
videos, and 
listening to 
music/radio 
Fitbit Flex Wrist   5.5 kcal  
Jawbone 
UP24 
Wrist   11.0 kcal  
Misfit 
Shine 
Wrist  18% 5.7 kcal  
Nike+ 
FuelBand 
SE 
Wrist  20% 6.5 kcal  
Bai et al. 
(2018) 
(41) 
Computer 
use, 
reading, 
and cell 
phone use 
Apple 
Watch 
Wrist 9% 22%  0.45 
Fitbit 
Charge 
HR 
Wrist 21% 35%  0.40 
Nelson et 
al. (2016) 
(50) 
Lying 
down, 
computer 
use, 
watching 
TV, writing, 
playing 
cards, and 
reading 
Fitbit Flex Wrist  14%   
Fitbit One Hip  13%   
Fitbit Zip Hip  16%   
Jawbone 
UP24 
Wrist -8% 17%   
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Table 9. Summary of Literature on Accuracy of Activity Monitors in Individuals with Diabetes. 
Summary of the existing scientific literature on accuracy of consumer-grade and research-grade activity 
monitors at measuring energy expenditure compared to indirect calorimetry in individuals with type 1 
diabetes. 
 
 
 
  
Authors 
Device 
Tested 
Wear 
Location 
Testing 
Protocol 
%RE 
Mean 
Difference 
95% LoA 
Pearson 
Correlation 
Machac et 
al. (2013) 
(57) 
OMRON 
HJ-720 
Hip Walking 
at 1.9 
mph and 
0% incline 
71%   0.77 
SenseWear 
Armband 
Pro3 
Arm 81%   0.79 
OMRON 
HJ-720 
Hip Walking 
at 2.5 
mph and 
0% incline 
76%   0.52 
SenseWear 
Armband 
Pro3 
Arm 78%   0.63 
OMRON 
HJ-720 
Hip Walking 
at 3.1 
mph and 
5% incline 
-7%   0.75 
SenseWear 
Armband 
Pro3 
Arm -8%   0.74 
Yavelberg 
et al. 
(2018) 
(56) 
Metria IH1 Arm 
Walking 
at ≤50% 
VO2 max 
4% 
0.3 
kcal/min 
-2.9 to 
3.5 
kcal/min 
 
Moderate-
to-
vigorous 
intensity 
(50-75% 
VO2 max) 
exercise 
circuit 
6% 
0.6 
kcal/min 
-2.6 to 
3.9 
kcal/min 
 
Vigorous-
to-
maximal 
intensity 
(75-100% 
VO2 max) 
exercise 
circuit 
-13% 
-1.8 
kcal/min 
-7.2 to 
3.7 
kcal/min 
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9.2. STUDY A 
 
Table 10. Participant Characteristics. Participant characteristics for Study A (n=20). 
Characteristic Value 
M / F 9 / 11 
Age (yr) 27.5 ± 6.0 
Height (cm) 173.2 ± 9.5 
Weight (kg) 67.9 ± 10.8 
Body Mass Index (kg/m2) 22.5 ± 2.3 
VO2 Peak (mL/min/kg) 48.0 ± 8.7 
Wrist (cm) 15.6 ± 2.0 
Race, n (%)  
Caucasian 17 (85) 
Asian 2 (10) 
Native American/Canadian 1 (5) 
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Table 11. Energy Expenditure. Pooled energy expenditure (EE) data for the different types of activities 
performed during Study A. Data are shown for each activity type for the Fitbit Charge 2 and Garmin 
vívosmart HR+. Sample size, mean ± SD EE reported by each device, mean ± SD EE reported by the 
reference standard, mean ± SD difference between the device measurement and the reference standard, 
mean relative difference ± SD (%) between the device measurement and the reference standard, mean 
absolute difference ± SD (%) between the device measurement and the reference standard, and 
correlation between the device measurement and the reference standard are presented in the table. 
 
Measures Fitbit Charge 2 Garmin vívosmart HR+ 
VO2 Peak Test (Treadmill) 
N 10 6 
Device Mean ± SD 192.1 ± 47.2 216.5 ± 55.3 
Criterion Mean ± SD 237.3 ± 72.5 260.5 ± 77.2 
Mean Difference ± SD -45.2 ± 44.4 -44.0 ± 90.1 
Mean Relative % Error ± SD -17.0 ± 14.6 -11.4 ± 33.7 
Mean Absolute % Error ± SD 19.4 ± 11.0 28.8 ± 17.2 
Pearson’s Correlation 0.81 0.11 
VO2 Peak Test (Cycle Ergometer) 
N 10 9 
Device Mean ± SD 133.6 ± 77.6 207.0 ± 48.7 
Criterion Mean ± SD 225.3 ± 74.7 231.4 ± 76.5 
Mean Difference ± SD -91.7 ± 87.2 -24.4 ± 63.9 
Mean Relative % Error ± SD -39.1 ± 30.6 -4.5 ± 25.3 
Mean Absolute % Error ± SD 43.5 ± 23.0 18.9 ± 16.2 
Pearson’s Correlation 0.35 0.56 
Resistance Exercise 
N 20 16 
Device Mean ± SD 130.2 ± 46.2 179.8 ± 56.8 
Criterion Mean ± SD 153.1 ± 45.5 155.2 ± 47.8 
Mean Difference ± SD -22.9 ± 44.0 24.6 ± 56.6 
Mean Relative % Error ± SD -12.9 ± 29.7 21.0 ± 35.7 
Mean Absolute % Error ± SD 27.7 ± 15.9 35.7 ± 19.7 
Pearson’s Correlation 0.54 0.43 
Activities of Daily Living 
N 20 18 
Device Mean ± SD 103.5 ± 38.2 100.6 ± 23.4 
Criterion Mean ± SD 114.4 ± 25.7 114.8 ± 27.0 
Mean Difference ± SD -10.9 ± 39.4 -14.3 ± 28.2 
Mean Relative % Error ± SD -8.8 ± 29.2 -10.6 ± 19.3 
Mean Absolute % Error ± SD 20.9 ± 21.8 17.0 ± 13.7 
Pearson’s Correlation 0.29 0.38 
High-Intensity Interval Training (Treadmill) 
N 10 9 
Device Mean ± SD 211.1 ± 57.0 226.9 ± 58.1 
Criterion Mean ± SD 246.6 ± 71.9 249.7 ± 75.6 
Mean Difference ± SD -35.5 ± 34.6 -22.8 ± 61.7 
Mean Relative % Error ± SD -13.1 ± 12.7 -4.7 ± 29.3 
Mean Absolute % Error ± SD 14.5 ± 10.9 25.0 ± 13.4 
Pearson’s Correlation 0.88 0.60 
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High-Intensity Interval Training (Cycle Ergometer) 
N 10 9 
Device Mean ± SD 128.2 ± 60.4 205.8 ± 76.4 
Criterion Mean ± SD 232.8 ± 44.2 234.9 ± 46.4 
Mean Difference ± SD -104.6 ± 83.8 -29.1 ± 80.2 
Mean Relative % Error ± SD -41.9 ± 31.3 -11.2 ± 30.8 
Mean Absolute % Error ± SD 41.9 ± 31.3 26.7 ± 17.0 
Pearson’s Correlation -0.26 0.22 
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Figure 1. Total Energy Expenditure. Total energy expenditure (kcal) measurements by the Cosmed 
K4b2/K5, Fitbit Charge 2, and Garmin vívosmart HR+ during the VO2 peak test (A), resistance exercise 
(B), activities of daily living (ADL) (C), and high-intensity interval training (HIIT) (D) in Study A. Each box-
whisker plot consists of a box that extends from the 25% to the 75% quantile, with a line in the middle of 
the box representing the median (50% quantile). Each box has error bars that extend to the 5% and 95% 
quantiles, with outliers displayed with closed circles. **P<0.01 compared to Cosmed. *P<0.05 compared 
to Fitbit. #P<0.0001 compared to Fitbit. 
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Figure 2. Correlation Plots for Total Energy Expenditure. Correlation plots comparing total energy 
expenditure (kcal) measurements from the Fitbit Charge 2 (FC2) (A,C,E,G) and Garmin vívosmart HR+ 
(GVHR+) (B,D,F,H) relative to the Cosmed K4b2/K5 during the VO2 peak test (A-B), resistance exercise 
(C-D), activities of daily living (ADL) (E-F), and high-intensity interval training (HIIT) (G-H) in Study A. The 
black solid line represents linear regression. The grey dotted line indicates the line of identity. n=6-20. 
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Figure 3. Absolute Percent Error in Energy Expenditure. Absolute percent error of the Fitbit Charge 2 
(FC2) and Garmin vívosmart HR+ (GVHR+) in measuring energy expenditure (EE) (kcal) during the VO2 
peak test, resistance exercise, activities of daily living (ADL), and high-intensity interval training (HIIT) in 
Study A. Each box-whisker plot consists of a box that extends from the 25% to the 75% quantile, with a 
line in the middle of the box representing the median (50% quantile). Each box has error bars that extend 
to the 5% and 95% quantiles, with outliers displayed with open circles. The P values listed on the right 
side display the difference in absolute percent error for EE between the FC2 and GVHR+ during each 
activity. n=15-20. *P<0.05. **P<0.01. 
 
 
 
 
 
 
 
 
Figure 4. Relative Percent Error in Energy Expenditure. Relative percent error of the Fitbit Charge 2 
(A) and Garmin vívosmart HR+ (B) in measuring energy expenditure (kcal) during the VO2 peak test on a 
treadmill (VO2 Peak-T) and cycle ergometer (VO2 Peak-C), resistance exercise, activities of daily living 
(ADL), and high-intensity interval training on a treadmill (HIIT-T) and cycle ergometer (HIIT-C) in Study A. 
The black horizontal lines represent the mean. The blue dashed lines indicate the 5% error threshold and 
the red dashed lines indicate the 10% error threshold. n=6-20. *P<0.05. #P<0.0001 compared to Garmin. 
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Figure 5. Bland-Altman Plots for Energy Expenditure. Bland-Altman plots comparing energy 
expenditure (EE) (kcal) measurements from the Fitbit Charge 2 (FC2) (A) and Garmin vívosmart HR+ 
(GVHR+) (B) relative to the Cosmed K4b2/K5 for all data in Study A, with each type of exercise 
represented by a different symbol. Mean EE of the Cosmed and FC2 or GVHR+ is displayed on the x-axis 
and the difference between the Cosmed and FC2 or GVHR+ is displayed on the y-axis. The black solid 
line indicates the mean difference (bias) between measurements and the black dashed lines indicate the 
limits of agreement. n=6-20. 
 
 
 
 
 
 
 
 
 
 
Figure 6. Relative Percent Error in Energy Expenditure for Treadmill and Cycle Ergometer 
Exercise. Relative percent error of the Fitbit Charge 2 and Garmin vívosmart HR+ in measuring energy 
expenditure (kcal) during the VO2 peak test and high-intensity interval training (HIIT) on the treadmill (A) 
and cycle ergometer (B) in Study A. The black horizontal lines represent the mean. The blue dashed lines 
indicate the 5% error threshold and the red dashed lines indicate the 10% error threshold. n=9-20. 
#P<0.0001. 
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Figure 7. Correlation Plots for Energy Expenditure. Correlation plots comparing energy expenditure 
(kcal/min) measurements from the Fitbit Charge 2 (FC2) relative to the Cosmed K4b2/K5 during the VO2 
peak test (A), resistance exercise (B), activities of daily living (ADL) (C), and high-intensity interval training 
(HIIT) (D), as well as all treadmill exercises combined (E) and all cycle ergometer exercises combined (F), 
in Study A. The black solid line identifies linear regression. The grey dotted line indicates the line of 
identity. n=10.  
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9.3. STUDY B 
 
Table 12. Participant Characteristics. Participant characteristics for Study B (n=15). 
Characteristic Total (n=15) T1D (n=9) Control (n=6) 
M / F 6 / 9 2 / 7 4 / 2 
Age (yr) 25.8 ± 8.1 24.9 ± 10.4 27.2 ± 2.1 
Height (cm) 170.1 ± 11.1 168.9 ± 11.1 172.0 ± 11.9 
Weight (kg) 70.0 ± 13.5 71.8 ± 13.0 67.3 ± 15.1 
Body Mass Index (kg/m2) 24.1 ± 3.4 25.0 ± 3.0 22.6 ± 3.6 
VO2 Peak (mL/min/kg) 42.9 ± 8.2 41.3 ± 5.9 45.3 ± 10.9 
Wrist (cm) 15.8 ± 1.4 16.0 ± 1.6 15.7 ± 1.3 
Race, n (%)    
Caucasian 14 (93) 9 (100) 5 (83) 
African American 1 (7) 0 (0) 1 (17) 
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Table 13. Energy Expenditure. Pooled energy expenditure (EE) data for the different types of activities 
performed during Study B. Data are shown for each activity type for the Fitbit Ionic and Garmin vívosmart 
3. Sample size, mean ± SD EE reported by each device, mean ± SD EE reported by the reference 
standard, mean ± SD difference between the device measurement and the reference standard, mean 
relative difference ± SD (%) between the device measurement and the reference standard, mean 
absolute difference ± SD (%) between the device measurement and the reference standard, and 
correlation between the device measurement and the reference standard are presented in the table. 
 
Measures Fitbit Ionic Garmin vívosmart 3 
VO2 Peak Test (Treadmill) 
N 12 12 
Device Mean ± SD 251.4 ± 110.7 249.9 ± 111.3 
Criterion Mean ± SD 251.5 ± 71.8 221.6 ± 64.3 
Mean Difference ± SD 0.1 ± 53.5 -28.3 ± 61.9 
Mean Relative % Error ± SD 7.4 ± 22.6 -4.6 ± 19.9 
Mean Absolute % Error ± SD 18.6 ± 14.0 16.4 ± 11.2 
Pearson’s Correlation 0.92 0.89 
Resistance Exercise 
N 13 11 
Device Mean ± SD 164.2 ± 47.0 168.2 ± 42.5 
Criterion Mean ± SD 254.5 ± 99.3 205.6 ± 73.2 
Mean Difference ± SD 90.3 ± 74.1 37.5 ± 83.2 
Mean Relative % Error ± SD 56.1 ± 44.4 28.6 ± 49.7 
Mean Absolute % Error ± SD 56.1 ± 44.4 44.6 ± 34.3 
Pearson’s Correlation 0.70 0.04 
Activities of Daily Living 
N 13 13 
Device Mean ± SD 112.8 ± 23.4 112.8 ± 23.4 
Criterion Mean ± SD 129.2 ± 44.6 123.8 ± 51.7 
Mean Difference ± SD 16.4 ± 28.4 11.0 ± 42.5 
Mean Relative % Error ± SD 12.9 ± 24.2 9.7 ± 35.0 
Mean Absolute % Error ± SD 21.6 ± 16.1 23.3 ± 27.1 
Pearson’s Correlation 0.83 0.59 
High-Intensity Interval Training (Treadmill) 
N 12 13 
Device Mean ± SD 259.0 ± 53.4 257.8 ± 51.3 
Criterion Mean ± SD 238.3 ± 54.6 248.6 ± 74.2 
Mean Difference ± SD -20.8 ± 29.6 -9.2 ± 69.9 
Mean Relative % Error ± SD -7.8 ± 10.5 -2.2 ± 26.1 
Mean Absolute % Error ± SD 11.0 ± 6.6 20.1 ± 15.8 
Pearson’s Correlation 0.85 0.43 
High-Intensity Interval Training (Cycle Ergometer) 
N 12 10 
Device Mean ± SD 230.3 ± 70.8 240.9 ± 72.6 
Criterion Mean ± SD 237.7 ± 77.8 242.4 ± 79.4 
Mean Difference ± SD 7.4 ± 68.2 1.5 ± 95.3 
Mean Relative % Error ± SD 6.8 ± 32.9 5.8 ± 43.1 
Mean Absolute % Error ± SD 28.5 ± 15.6 34.3 ± 24.2 
Pearson’s Correlation 0.58 0.22 
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Figure 8. Total Energy Expenditure. Total energy expenditure (kcal) measurements by the Cosmed K5, 
Fitbit Ionic, and Garmin vívosmart 3 during the VO2 peak test (A), resistance exercise (B), activities of 
daily living (ADL) (C), and high-intensity interval training (HIIT) on a treadmill (D) and cycle ergometer (E) 
in Study B. Each box-whisker plot consists of a box that extends from the 25% to the 75% quantile, with a 
line in the middle of the box representing the median (50% quantile). Each box has error bars that extend 
to the 5% and 95% quantiles, with outliers displayed with closed circles. *P<0.05 compared to Cosmed. 
**P<0.01 compared to Cosmed. 
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Figure 9. Correlation Plots for Total Energy Expenditure. Correlation plots comparing total energy 
expenditure (kcal) measurements from the Fitbit Ionic (FI) (A,C,E,G,I) and Garmin vívosmart 3 (GV3) 
(B,D,F,H,J) relative to the Cosmed K5 during the VO2 peak test (A-B), resistance exercise (C-D), activities 
of daily living (ADL) (E-F), and high-intensity interval training (HIIT) on a treadmill (G-H) and cycle 
ergometer (I-J) in Study B. The black solid line identifies linear regression for T1D subject data and the 
black dashed line identifies linear regression for control subject data. The grey dotted line indicates the 
line of identity. n=10-13. 
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Figure 10. Absolute Percent Error in Energy Expenditure. Absolute percent error of the Fitbit Ionic (FI) 
and Garmin vívosmart 3 (GV3) in measuring energy expenditure (EE) (kcal) during the VO2 peak test, 
resistance exercise, activities of daily living (ADL), and high-intensity interval training (HIIT) on a treadmill 
and cycle ergometer in Study B. Each box-whisker plot consists of a box that extends from the 25% to the 
75% quantile, with a line in the middle of the box representing the median (50% quantile). Each box has 
error bars that extend to the 5% and 95% quantiles, with outliers displayed with open circles. The P 
values listed on the right side display the difference in absolute percent error for EE between the FI and 
GV3 during each activity. n=10-13. *P<0.05 compared to Resistance. 
 
 
 
 
 
 
 
 
 
Figure 11. Relative Percent Error in Energy Expenditure. Relative percent error of the Fitbit Ionic (A) 
and Garmin vívosmart 3 (B) in measuring energy expenditure (kcal) during the VO2 peak test, resistance 
exercise, activities of daily living (ADL), and high-intensity interval training on a treadmill (HIIT-T) and 
cycle ergometer (HIIT-C) in Study B. The black horizontal lines represent the mean. The blue dashed 
lines indicate the 5% error threshold and the red dashed lines indicate the 10% error threshold. n=10-13. 
‡P<0.05 compared to Garmin. *P<0.05 compared to Resistance. §P<0.001 compared to Resistance. 
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Figure 12. Bland-Altman Plots for Energy Expenditure. Bland-Altman plots comparing energy 
expenditure (EE) (kcal) measurements from the Fitbit Ionic (FI) (A) and Garmin vívosmart 3 (GV3) (B) 
relative to the Cosmed K5 for all data in Study B, with each type of exercise represented by a different 
symbol. Mean EE of the Cosmed and FI or GV3 is displayed on the x-axis and the difference between the 
Cosmed and FI or GV3 is displayed on the y-axis. The black solid line indicates the mean difference 
(bias) between measurements and the black dashed lines indicate the limits of agreement. n=10-13. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Relative Percent Error in Energy Expenditure for Treadmill and Cycle Ergometer 
Exercise. Relative percent error of the Fitbit Ionic and Garmin vívosmart 3 in measuring energy 
expenditure (kcal) during the VO2 peak test and high-intensity interval training (HIIT) on the treadmill (A) 
and cycle ergometer (B) in Study B. The black horizontal lines represent the mean. The blue dashed lines 
indicate the 5% error threshold and the red dashed lines indicate the 10% error threshold. n=10-13. 
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Figure 14. Relative Percent Error in Energy Expenditure in T1D and Control Subjects. Relative 
percent error of the Fitbit Ionic (A) and Garmin vívosmart 3 (B) in measuring energy expenditure (kcal) in 
T1D and control subjects in Study B. The black horizontal lines represent the mean. The blue dashed 
lines indicate the 5% error threshold and the red dashed lines indicate the 10% error threshold. n=5-9. 
#P<0.0001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Blood Glucose. Blood glucose (BG) from pre- to post-exercise in T1D and control subjects 
during visit 1 and visit 2 in Study B. BG measurements were taken using SMBG. 
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Figure 16. Change in Blood Glucose. Change in blood glucose in T1D (A) and control subjects (B) from 
the start to the end of the VO2 peak test, resistance exercise, activities of daily living (ADL), and high-
intensity interval training on a treadmill (HIIT-T) and cycle ergometer (HIIT-C) in Study B. BG 
measurements were taken using SMBG. The black horizontal lines represent the mean. n=2-9. *P<0.05 
compared to T1D. 
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Figure 17. Percent Time in Hypoglycemia, Euglycemia, and Hyperglycemia. Percent time spent in 
hypoglycemia, euglycemia, and hyperglycemia during exercise (A) and for 12 hours post-exercise (B) in 
visit 1 and during exercise (C) and for 12 hours post-exercise (D) in visit 2 by T1D and control subjects in 
Study B. Glucose measurements were taken using CGM. All data are mean ± SD. 
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Figure 18. Interstitial Glucose. Interstitial glucose tracings from CGM for 12 hours post-exercise 
following visit 1 (A) and visit 2 (B) in T1D subjects and 1 control subject. The grey area represents 
euglycemia (3.9-10 mmol/L). All data are mean ± SD. 
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10. APPENDICES 
 
10.1. STUDY A 
 
Appendix A. Activity Modes. Activity modes used on the Fitbit Charge 2 and Garmin vívosmart HR+ 
during the VO2 peak test on a treadmill (VO2 Peak-T) and cycle ergometer (VO2 Peak-C), resistance 
exercise, activities of daily living (ADL), and high-intensity interval training on a treadmill (HIIT-T) and 
cycle ergometer (HIIT-C) in Study A. 
 
 Fitbit Charge 2 Garmin vívosmart HR+ 
VO2 Peak – T Run Run 
VO2 Peak – C Bike Cardio 
Resistance Weights Other 
ADL Workout Walk 
HIIT – T Run Run 
HIIT – C Bike Cardio 
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Appendix B. Energy Expenditure for Individual Subjects during Cycling Exercise. Energy 
expenditure (kcal/min) measurements for individual subjects (e.g. YU02) from the Fitbit Charge 2 during 
the VO2 peak test (A,C,E,G,I) and high-intensity interval training (HIIT) (B,D,F,H,J) on the cycle ergometer 
in Study A. 
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Appendix C. Relative Percent Error in Energy Expenditure for Dominant and Non-Dominant Hand 
Wear. Relative percent error of the Fitbit Charge 2 (A) and Garmin vívosmart HR+ (B) in measuring 
energy expenditure (kcal) during dominant hand and non-dominant hand wear in Study A. The black 
horizontal lines represent the mean. The blue dashed lines indicate the 5% error threshold and the red 
dashed lines indicate the 10% error threshold. n=4-6. 
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Appendix D. Correlation Plots for Relative Percent Error and Anthropometrics. Correlation plots 
comparing relative percent error in energy expenditure measurements (kcal) from the Fitbit Charge 2 
(FC2) (A,C,E,G,I,K,M,O,Q,S,U,W) and Garmin vívosmart HR+ (GVHR+) (B,D,F,H,J,L,N,P,R,T,V,X) to 
subject’s age (A-B), height (C-D), weight (E-F), BMI (G-H), body fat percentage (I-J), lean body mass (K-
L), waist circumference (M-N), wrist circumference (O-P), systolic blood pressure (Q-R), diastolic blood 
pressure (S-T), resting heart rate (U-V), and VO2 peak (W-X) in Study A. The black solid line identifies 
linear regression. n=6-20. 
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Appendix E. Relative Percent Error in METs and VO2. Relative percent error of the Fitbit Charge 2 in 
measuring METs (A) and VO2 (B) during the VO2 peak test on a treadmill (VO2 Peak-T) and cycle 
ergometer (VO2 Peak-C), resistance exercise, activities of daily living (ADL), and high-intensity interval 
training on a treadmill (HIIT-T) and cycle ergometer (HIIT-C) in Study A. The black horizontal lines 
represent the mean. The blue dashed lines indicate the 5% error threshold and the red dashed lines 
indicate the 10% error threshold. n=10-20. *P<0.05 compared to ADL. 
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10.2. STUDY B 
 
Appendix F. Activity Modes. Activity modes used on the Fitbit Ionic and Garmin vívosmart 3 during the 
VO2 peak test, resistance exercise, activities of daily living (ADL), and high-intensity interval training on a 
treadmill (HIIT-T) and cycle ergometer (HIIT-C) in Study B. 
 
 Fitbit Ionic Garmin vívosmart 3 
VO2 Peak Treadmill Run 
Resistance Weights Other 
ADL Workout Walk 
HIIT – T Treadmill Run 
HIIT – C Bike Cardio 
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Appendix G. Relative Percent Error in Energy Expenditure on Garmin vívosmart 3. Relative percent 
error in measuring energy expenditure (kcal) on the Garmin vívosmart 3 (GV3) during the VO2 peak test 
(A), resistance exercise (B), activities of daily living (ADL) (C), and high-intensity interval training (HIIT) on 
a treadmill (D) and cycle ergometer (E) in Study B. The black horizontal lines represent the mean. The 
blue dashed lines indicate the 5% error threshold and the red dashed lines indicate the 10% error 
threshold. n=10-13. *P<0.05. **P<0.01. 
  
148 
 
 
Appendix H. Fitzpatrick Skin Tone Score and Body Fat Percentage in T1D and Control Subjects. 
Fitzpatrick skin tone score (A) and body fat percentage (B) of T1D and control subjects in Study B. The 
black horizontal lines represent the mean. n=6-9. *P<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix I. Relative Percent Error in Energy Expenditure for Dominant and Non-Dominant Hand 
Wear. Relative percent error of the Fitbit Ionic (A) and Garmin vívosmart 3 (B) in measuring energy 
expenditure (kcal) during dominant hand and non-dominant hand wear in Study B. The black horizontal 
lines represent the mean. The blue dashed lines indicate the 5% error threshold and the red dashed lines 
indicate the 10% error threshold. n=6-8. 
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Appendix J. Correlation Plots for Relative Percent Error and Anthropometrics. Correlation plots 
comparing relative percent error in energy expenditure measurements (kcal) from the Fitbit Ionic (FI) 
(A,C,E,G,I,K,M,O,Q,S,U,W,Y,AA) and Garmin vívosmart 3 (GV3) (B,D,F,H,J,L,N,P,R,T,V,X,Z,BB) to 
subject’s age (A-B), height (C-D), weight (E-F), BMI (G-H), body fat percentage (I-J), lean body mass (K-
L), waist circumference (M-N), wrist circumference (O-P), systolic blood pressure (Q-R), diastolic blood 
pressure (S-T), resting heart rate (U-V), VO2 peak (W-X), Von Lushan skin tone score (Y-Z), and 
Fitzpatrick skin tone score (AA-BB) in Study B. The black solid line identifies linear regression for T1D 
subject data and the black dashed line identifies linear regression for control subject data. n=10-13. 
